Market Research Logo

Novel Cell Sorting and Separation Market: Focus on Acoustophoresis, Buoyancy-activated, Dielectrophoresis, Magnetophoretics, Microfluidics, Optoelectronics, Photoacoustics, Traceless Affinity and Other Technologies, 2019-2030

Novel Cell Sorting and Separation Market: Focus on Acoustophoresis, Buoyancy-activated, Dielectrophoresis, Magnetophoretics, Microfluidics, Optoelectronics, Photoacoustics, Traceless Affinity and Other Technologies, 2019-2030

Advances in the fields of cell biology and regenerative medicine have led to the development of various cell-based therapies, which, developers claim, possess the potential to treat a variety of clinical conditions. In 2018, it was reported that there were more than 1,000 clinical trials of such therapies, being conducted across the globe by over 900 industry players. Moreover, the total investment in the aforementioned clinical research efforts was estimated to be around USD 13 billion. Given the recent breakthroughs in clinical testing and the discovery of a variety of diagnostic biomarkers, the isolation of one or multiple cell types from a heterogenous population has not only become simpler, but also an integral part of modern clinical R&D. The applications of cell separation technologies are vast, starting from basic research to biological therapy development and manufacturing. However, conventional cell sorting techniques, including adherence-based sorting, membrane filtration-based sorting, and fluorescence- and magnetic-based sorting, are limited by exorbitant operational costs, time-consuming procedures, and the need for complex biochemical labels. As a result, the use of such techniques has, so far, been restricted in the more niche and emerging application areas.

Over the years, extensive research in the field of flow cytometry has enabled the development of a variety of novel technologies that are capable of efficiently isolating cells from tissue samples and / or heterogenous cell populations. In fact, since 2014, over 3,000 patents were reported to have been filed / granted related to such advanced techniques, indicating the rapid pace of innovation in this domain. Developers of the aforementioned technologies claim that these new techniques offer numerous benefits, including fast and precise cell sorting, reduced sample requirement, improved portability, reduced risk to cell viability, and negligible need for expensive biochemical / magnetic labels. Moreover, they have been shown to be compatible for use across a myriad of applications, including research studies (bacteriology, immunology, stem cell research, and viral titering and infectivity), biomedical diagnostics (circulating tumor cell detection, in vitro fertilization, and non-invasive prenatal diagnosis), biological therapy-related process operations (bio-banking, drug discovery, sample preparation, single cell sequencing, and tumor cell characterization), and cell-based therapeutics (B- or T-cell immunotherapies). Consequently, these techniques have captured the interest of several stakeholders in the biopharmaceutical industry. It is also worth highlighting that stakeholders in this domain have received significant support from both private and public investors.

SCOPE OF THE REPORT
The ‘Novel Cell Sorting and Separation Market: Focus on Acoustophoresis, Buoyancy-activated, Dielectrophoresis, Magnetophoretics, Microfluidics, Optoelectronics, Photoacoustics, Traceless Affinity and Other Technologies, 2019-2030’ report features an extensive study of the current landscape and future outlook of the growing market for novel cell sorting and separation technologies (beyond conventional methods). The study presents detailed analyses of cell sorters, cell isolation kits, and affiliated consumables and reagents, that are based on the aforementioned technologies. Amongst other elements, the report features:

A detailed assessment of the current market landscape, featuring a comprehensive list of over 220 innovative cell sorters, cell isolation kits, and affiliated consumables and reagents, along with information on their respective specifications (such as size, weight, cell flow rate, cell sort rate, cell analysis rate, cell purity and viability, process time, and operating temperature and pressure), cell sorting technology (acoustophoresis, buoyancy-activated, dielectrophoresis, magnetophoretics, microfluidics, optoelectronics, photoacoustics, traceless affinity, and others), type of cell (animal cells, cancer cells, immune cells, microbial cells, red blood cells / platelets, stem cells, and others), cell separation approach (positive selection, negative selection and depletion), basis for separation (cell morphology and physiology, cell size and density, surface biomarkers, surface charge and adhesion, and others), and end use / application (research studies, biomedical diagnostics, biological therapy-related process operations, and cell-based therapeutics).

An insightful company competitiveness analysis, taking into consideration the supplier power (based on size of employee base and experience in this segment of the industry) and portfolio-related parameters, such as number of products offered, number of target cells, end use(s) / application(s), and key product specification(s).

Comprehensive profiles of key industry players (shortlisted on the basis of company competitiveness analysis scores) that are currently offering novel cell sorters / consumables and cell isolation kits, featuring an overview of the company, its financial information (if available), and a detailed description of its proprietary product(s). Each profile also includes a list of recent developments, highlighting the key achievements, partnership activity, and the likely strategies that may be adopted by these players to fuel growth in the foreseen future.

An in-depth analysis of the patents that have been filed / granted related to novel cell sorting and separation technologies, since 2014. It highlights the key trends associated with these patents, across patent type, regional applicability, CPC classification, emerging focus areas, leading industry players (in terms of number of patents filed / granted), and current intellectual property-related benchmarks and valuation.

A detailed publication analysis of more than 200 peer-reviewed, scientific articles that have been published since 2014, highlighting the research focus within the industry. It also highlights the key trends observed across the publications, including information on innovative technologies, potential application areas, target disease indications, type of cell, and analysis based on various relevant parameters, such as year of publication, and most popular journals (in terms of number of articles published in the given time period) within this domain.

An analysis of the partnerships that have been established in the domain, in the period 2014-Q1 2019, covering R&D collaborations, licensing agreements, distribution agreements, mergers / acquisitions, asset purchase agreements, product development agreements, product utilization agreements, and other relevant deals.

An analysis of the investments made at various stages of development, such as seed financing, venture capital financing, debt financing, grants / awards, capital raised from IPOs and subsequent offerings, by companies that are engaged in this field.

An analysis to estimate the likely demand for novel cell sorting products and solutions across key application areas, including research studies, clinical diagnostics, cell-based therapeutics, and other applications, in different global regions for the period 2019-2030.

One of the key objectives of the report was to understand the primary growth drivers and estimate the future size of the novel cell sorting and separation market. Based on multiple parameters, such as potential application areas, likely adoption rate and expected pricing, we have provided an informed estimate on the likely evolution of the market, over the period 2019-2030. In addition, we have provided the likely distribution of the current and forecasted opportunity across [A] potential application areas (research studies, clinical diagnostics, cell-based therapeutics, and other applications), [B] end users (academic institutes, clinical testing labs, hospitals, and commercial organizations), [C] type of offering (cell sorters, and consumables and isolation kits), [D] cell sorting technology (buoyancy-activated, magnetophoretics, microfluidics, optoelectronics, and other advanced technologies), [E] type of cell (adult stem cells, CAR-T cells, circulating fetal cells, circulating tumor cells, dendritic cells, embryonic stem cells, insect cells, induced pluripotent stem cells, microbial cells, sperm cells, TCR cells, TILs, and tumor cells / cancer cells), [F] size of cell (< 5 µm, 5-10 µm, 10-15 µm, 15-25 µm, and > 25 µm), and [G] key geographical regions (North America, Europe and Asia-Pacific). In order to account for the uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios portraying the conservative, base and optimistic tracks of the industry’s evolution.

The opinions and insights presented in this study were also influenced by discussions conducted with multiple stakeholders in this domain. The report features detailed transcripts of interviews held with the following individuals (in alphabetical order of organization names):
John Younger (Co-founder and Chief Technology Officer, Akadeum Life Sciences)
Sean Hart (Chief Executive Officer and Chief Scientific Officer, LumaCyte)
Soohee Cho (Product Manager, Namocell)

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

RESEARCH METHODOLOGY
The data presented in this report has been gathered via secondary and primary research. For all our projects, we conduct interviews with experts in the area (academia, industry and other associations) to solicit their opinions on emerging trends in the market. This is primarily useful for us to draw out our own opinion on how the market will evolve across different regions and technology segments. Where possible, the available data has been checked for accuracy from multiple sources of information.

The secondary sources of information include
Annual reports
Investor presentations
SEC filings
Industry databases
News releases from company websites
Government policy documents
Industry analysts’ views

While the focus has been on forecasting the market till 2030, the report also provides our independent view on various non-commercial trends emerging in the industry. This opinion is solely based on our knowledge, research and understanding of the relevant market gathered from various secondary and primary sources of information.

CHAPTER OUTLINES
Chapter 2 is an executive summary of the insights captured in our research. It offers a high-level view on the likely evolution of novel cell sorting and separation market in the mid-long term.

Chapter 3 is an introductory chapter that presents a general overview of cell sorting and separation, including a brief history of development, and information on the basic components and principle of operation of a cell sorter. Further, it features a detailed discussion on conventional cell separation techniques and the various challenges associated with their use across different application areas. The chapter also includes detailed sections on the novel cell sorting and separation technologies (such as acoustophoresis, buoyancy-activated, dielectrophoresis, magnetophoretics, microfluidics, optoelectronics, photoacoustics, traceless affinity, and others), highlighting their advantages and challenges. Further, it features a discussion on the key growth drivers and roadblocks related to modern cell sorting technologies, as well as upcoming trends that the field is expected to witness in the coming years.

Chapter 4 includes information on more than 220 innovative cell sorters, cell isolation kits, and affiliated consumables and reagents, along with details on their respective specifications (such as size, weight, cell flow rate, cell sort rate, cell analysis rate, cell purity and viability, process time, and operating temperature and pressure), cell sorting technology (acoustophoresis, buoyancy-activated, dielectrophoresis, magnetophoretics, microfluidics, optoelectronics, photoacoustics, traceless affinity, and others), type of cell (animal cells, cancer cells, microbial cells, red blood cells / platelets, stem cells, and others), cell separation approach (positive selection, negative selection and depletion), basis for separation (cell morphology and physiology, cell size and density, surface biomarkers, surface charge and adhesion, and others), and end use / application (research studies, biomedical diagnostics, biological therapy-related process operations, and cell-based therapeutics). The chapter also highlights the contributions of various companies engaged in this domain, presenting detailed analyses, based on their year of establishment, size of employee base, geographical presence, and type of offering.

Chapter 5 features an insightful competitiveness analysis of the companies engaged in novel cell sorting and separation domain, based on various parameters, such as number of products offered, number of target cells, end use(s) / application(s), and key product specification(s). In the chapter, stakeholder entities have been plotted on a 2X2 matrix, featuring a company’s Supplier Power (based on size of employee base and experience in this segment of the industry) and Company Competitiveness as the two axes.

Chapter 6 includes elaborate profiles of key industry players (shortlisted on the basis of company competitiveness analysis scores) that are offering novel cell sorters / sorting technologies; each profile features an overview of the company, its financial information (if available), and a detailed description of its proprietary product(s). Each profile also includes a list of recent developments, highlighting the key achievements, partnership activity, and the likely strategies that may be adopted by these players to fuel growth, in the foreseen future.

Chapter 7 includes detailed profiles of key industry players (shortlisted on the basis of company competitiveness analysis scores) that are offering novel consumables and cell isolation kits; each profile features an overview of the company, its financial information (if available), and a detailed description of its proprietary product(s). Each profile also includes a list of recent developments, highlighting the key achievements, partnership activity, and the likely strategies that may be adopted by these players to fuel growth, in the foreseen future.

Chapter 8 provides an in-depth patent analysis to provide an overview of how the industry is evolving from the R&D perspective. For this analysis, we considered those patents that have been filed / granted related to novel cell sorting and separation technologies, since 2014. The analysis also highlights the key trends associated with these patents, across patent type, regional applicability, CPC classification, emerging focus areas, leading industry players (in terms of number of patents filed / granted), and current intellectual property-related benchmarks and valuation.

Chapter 9 presents a detailed publication analysis of more than 200 peer-reviewed, scientific articles that have been published since 2014, highlighting the research focus within the industry. It also highlights the key trends observed across the publications, including information on innovative technologies, potential application areas, target disease indications, type of cell, and analyses based on various relevant parameters, such as year of publication, and most popular journals (in terms of number of articles published in the given time period) within this domain.

Chapter 10 features an elaborate analysis and discussion of partnerships / collaborations that have been established in this domain in the period 2014-Q1 2019. It includes a brief description of various types of partnership models (such as R&D collaborations, licensing agreements, distribution agreements, mergers / acquisitions, asset purchase agreements, product development agreements, product utilization agreements, and others) that have been employed by stakeholders within this domain. It also consists of a schematic representation showcasing the players that have established the maximum number of alliances related to novel cell sorting and separation technologies. Furthermore, we have provided a world map representation of all the deals inked in this field, highlighting those that have been established within and across different continents.

Chapter 11 provides information on funding instances and investments that have been made within the novel cell sorting and separation domain. The chapter includes details on various types of investments (such as seed financing, venture capital financing, debt financing, grants, capital raised from IPOs and subsequent offerings) received by companies in the period 2014-Q1 2019, highlighting the growing interest of the venture capital community and other strategic investors in this domain.

Chapter 12 provides an overview of the demand for novel cell sorting products and solutions across key application areas, including research studies, clinical diagnostics, cell-based therapeutics, and other applications, in the contemporary market. In order to estimate the aforementioned demand, we considered the number of ongoing / completed research studies, diagnostic tests and cell-based therapies under development across different geographies. We also estimated the likely adoption of such products and solutions across key application areas, over the period 2019-2030.

Chapter 13 features a comprehensive market forecast, highlighting the future potential of novel cell sorting and separation market till 2030, based on multiple parameters, such as potential application areas, likely adoption rate and expected pricing. In addition, we estimated the likely distribution of the current and forecasted opportunity across [A] potential application areas (research studies, clinical diagnostics, cell-based therapeutics, and other applications), [B] end users (academic institutes, clinical testing labs, hospitals, and commercial organizations), [C] type of offering (cell sorters, and consumables and isolation kits), [D] cell sorting technology (buoyancy-activated, magnetophoretics, microfluidics, optoelectronics, and other advanced technologies), [E] type of cell (adult stem cells, CAR-T cells, circulating fetal cells, circulating tumor cells, dendritic cells, embryonic stem cells, insect cells, induced pluripotent stem cells, microbial cells, sperm cells, TCR cells, TILs, and tumor cells / cancer cells), [F] size of cell (< 5 µm, 5-10 µm, 10-15 µm, 15-25 µm, and > 25 µm), and [G] key geographical regions (North America, Europe and Asia-Pacific). We adopted a combination of top-down and bottom up approaches, backed by robust data and credible inputs from primary research, to estimate the likely size of the market, both in terms of value (USD billion) and volume (number of products).

Chapter 14 is a collection of executive insights of the discussions that were held with various key stakeholders in this market. The chapter provides a brief overview of the companies and details of interviews held with John Younger (Co-founder and Chief Technology Officer, Akadeum Life Sciences), Sean Hart (Chief Executive Officer and Chief Scientific Officer, LumaCyte), and Soohee Cho (Product Manager, Namocell).

Chapter 15 is a summary of the overall report. In this chapter, we have provided a list of key takeaways from the report, and expressed our independent opinion related to the research and analysis described in the previous chapters.

Chapter 16 is an appendix, which provides tabulated data and numbers for all the figures provided in the report.

Chapter 17 is an appendix, which contains the list of companies and organizations mentioned in the report.

LIST OF COMPANIES AND ORGANIZATIONS

The following companies / institutes / government bodies and organizations have been mentioned in this report.

1. 1087systems
2. 48Hour Discovery
3. 5AM Ventures
4. Abbott
5. AbbVie
6. Academia Sinica
7. Academic Medical Centre
8. Academy of Military Medical Sciences
9. Accelerate Diagnostics
10. ACEA Biosciences
11. AcouSort
12. Active Biotech
13. Adaptive Biotechnologies
14. Adelaide Research & Innovation
15. AdnaGen
16. ADS BIOTEC
17. Advanced Virus Detection Technologies Interest Group
18. Aegea Biotechnologies
19. Aenitis Technologies
20. Agency for Science, Technology and Research
21. Agilent Technologies
22. AIM Group International
23. AIMM Therapeutics
24. Akadeum Life Sciences
25. Albert Einstein College of Medicine
26. Alder BioPharmaceuticalss
27. Alexion Pharmaceuticals
28. Alkem Laboratories
29. Amazentis
30. Ambergen
31. American Institute of Health
32. Amgen
33. AnaptysBio
34. Ancera
35. Angel HQ
36. Angel Round Capital Fund
37. ANGLE
38. Ann & Robert H Lurie Children's Hospital of Chicago
39. ANSYS
40. Anzu Partners
41. ApoCell
42. Argonaut Manufacturing Services
43. arivis
44. Artiman Ventures
45. Ascent Bio-Nano Technologies
46. Ascus Biosciences
47. Astellas Pharma
48. Augusta University
49. Aurora Life Technologies
50. AVIVA Biosciences
51. Barts Cancer Institute
52. Base4 Innovation
53. Bay City Capital
54. Bayer
55. BC Cancer Agency
56. Beckman Coulter
57. Becton Dickinson
58. Beijing Genomics Institute
59. Beth Israel Deaconess Medical Center
60. Betta Pharmaceuticals
61. BGI Group
62. Biocept
63. Bioceptive
64. BioCrine
65. BioFluidica
66. BioInfleXion Point Partners
67. BIOKÉ
68. Biolidics
69. BioMEMS Resource Center
70. BioMimetic Therapeutics
71. Bio-Rad Laboratories
72. BIOSS
73. Bio-Techne
74. BioTheranostics
75. BioView
76. Boehringer Ingelheim
77. Boyalife Group
78. Bpifrance
79. Brigham and Women's Hospital
80. Bristol-Myers Squibb
81. Broad Institute
82. Bucher Biotec
83. C4 Therapeutics
84. California Institute of Technology
85. California NanoSystems Institute
86. Caltag Medsystems
87. Cambridge Consultants
88. Cambridge Enterprise
89. Canary Center at Stanford
90. Cancer Genetics
91. Cancer Institute of Greenville Health System
92. Cancer Metastasis Laboratory, University of Basel
93. Cancer Research UK Manchester Institute
94. CANCER-ID
95. Canon US Life Sciences
96. Capio Biosciences
97. Caris Life Sciences
98. Carnegie Mellon University
99. Case Western Reserve University
100. Catalyst Biosciences
101. Celgene
102. Cell Microsystems
103. Cell Signaling Technology
104. Cell.Copedia
105. Cellaviva
106. CellectCell
107. Cellenion
108. Cellix
109. CellMax Life
110. Celsee
111. Center for Advanced Medical Products
112. Centre Léon Bérard
113. Cephalon
114. Cesca Therapeutics
115. CFD Research
116. Chang Gung Memorial Hospital
117. ChemoCentryx
118. Chinese Academy of Medical Sciences
119. Cincinnati Children's Hospital Medical Center
120. Cipla
121. Clinomics
122. Columbia University
123. Cornell University
124. Corning
125. Creative BioArray
126. Creative Diagnostics
127. CREST
128. CRV International
129. CureGene
130. Cytonome
131. CytoVale
132. Cytovance Biologics
133. Dana-Farber Cancer Institute
134. Danaher
135. DAON BioSciences
136. Decheng Capital
137. Department of Biomedical Engineering, Lund University
138. Detroit Innovate
139. DiaSorin
140. Diffusion Capital Partners
141. Draper Laboratory
142. Duke University
143. eFFECTOR Therapeutics
144. Eisai
145. EKF Diagnostics
146. eLab Ventures
147. Eli Lilly
148. EMV Capital
149. Engender Technologies
150. Enlivex Therapeutics
151. Enterprise Angels
152. Epic Sciences
153. Evercyte
154. EXONBio
155. Fiona Stanley Hospital
156. Five3 Genomics
157. FloDesign Sonics
158. Florida Cancer Specialists and Research Institute
159. Fluidigm
160. France Innovation Scientifique et Transfert
161. French National Center for Scientific Research
162. Fudan University Shanghai Cancer Center
163. FusionX Ventures
164. GE Healthcare
165. GenapSys
166. Genentech
167. General Automation Lab Technologies
168. Genewiz
169. Genial Laboratory Automation
170. Genoa Ventures
171. Georgetown University
172. Georgia Tech Research Institute
173. Gilead Sciences
174. GILUPI
175. Glass Capital Management
176. GlaxoSmithKline
177. Glenmark Pharmaceuticals
178. GOM
179. Grace Bio-Labs
180. Greenwoods Asset Management
181. GRI Bio
182. Guangxi Academy of Sciences
183. Hahn-Schickard
184. Halcyon Biomedical
185. Halozyme Therapeutics
186. Harvard Stem Cell Institute
187. Harvard University
188. Horizon Discovery
189. Hubei Cancer Clinical Study Center
190. Humacyte
191. Humanitas Research Hospital
192. Hunan Agen Medicine Laboratory Technology
193. IBA Lifesciences
194. Icahn School of Medicine
195. ICE Angels
196. iCellate
197. ICREA
198. Ignyta
199. Illumina Ventures
200. IMEC
201. immatics biotechnologies
202. Immunomedics
203. ImmunoQure
204. Inabata
205. Inbiomotion
206. IncellDx
207. IncoCell Tianjin
208. Incyte
209. Inguran
210. Innate Pharma
211. Innovate UK
212. Innovative Biochips
213. Innovative Micro Technology
214. Inova
215. Institute of Cancer Research, London
216. Institute of Organic Chemistry and Biochemistry
217. Instrumentation Laboratory
218. Intrinsic LifeSciences
219. Invention Science Fund
220. Invest Michigan
221. Invetech
222. iPS Portal
223. Janssen Biotech
224. Japan Science and Technology Agency
225. Jiulongpo District People's Hospital
226. Jiva Sciences
227. John Hopkins University
228. John Wayne Cancer Institute
229. Jonsson Comprehensive Cancer Center
230. Karolinska Institute
231. Kataoka
232. Katholieke Universiteit Leuven
233. Keswick Ventures
234. Kiyatec
235. Koek Biotechnology
236. Kymab
237. LabCorp
238. Landos Biopharma
239. Lawson Health Research Institute
240. Leica Biosystems
241. LevitasBio
242. LG Electronics
243. LIDE Biotech
244. Life Technologies
245. Livzon Pharmaceuticals
246. London Business Angels
247. LPATH
248. LumaCyte
249. Luminex
250. LungLifeAI
251. Lupin
252. Mackay Memorial Hospital
253. Massachusetts Institute of Technology
254. Mayo Clinic Foundation
255. MD Anderson Cancer Center
256. MDxK
257. Medigen Biotech
258. MeMed Diagnostics
259. Memorial Sloan Kettering Cancer Center
260. Menarini Silicon Biosystems
261. Merck
262. Metabiota
263. Microbix Biosystems
264. MicroMedicine
265. Middle East Technical University
266. Mikro Biyosistemler
267. Mikro Systems
268. Millennium Pharmaceuticals
269. MilliporeSigma
270. Miltenyi Biotec
271. Morehouse School of Medicine
272. Morphotek
273. Mumbai Angels
274. Namocell
275. NanoCellect Biomedical
276. Nanosphere
277. NanoTag Biotechnologies
278. National Cancer Centre Singapore
279. National Cancer Institute
280. National Center for Emerging and Zoonotic Infectious Diseases
281. National Center for Nanoscience and Technology
282. National Institute for Health Research
283. National Institute for Innovation in Manufacturing Biopharmaceuticals
284. National Institute of Drug Abuse
285. National Institute of General Medical Sciences
286. National Institutes of Health
287. National University Hospital
288. National University of Ireland Galway’s Regenerative Medicine Institute
289. National University of Singapore
290. Naval Research Laboratory
291. Nektar Therapeutics
292. NeoDiagnostix
293. NeuroVision Pharma
294. New York Upstate Cord Blood Bank
295. New Zealand Venture Investment Fund
296. Newable Private Investing
297. NextGem
298. Nodality
299. Northeastern University
300. Northwestern University
301. Novartis
302. Novo Nordisk
303. Ohio State Innovation Foundation
304. On-chip Biotechnologies
305. Oregon Health & Science University
306. Organovo
307. Ortho Clinical Diagnostics
308. Orthohealing Center Management
309. Osaka University Venture Capital
310. Owl biomedical
311. OYAK
312. Pacific Biosciences
313. Pacific Channel
314. Packers Sanitation Services
315. Parkwalk Advisors
316. Partec
317. Penn State Research Foundation
318. PerkinElmer
319. Pfizer
320. Pharmaxis
321. Philips
322. Phywe
323. pluriSelect Life Science
324. Purdue Research Foundation
325. Qiagen
326. Quad Technologies
327. Qventures
328. R&D Systems
329. RareCyte
330. Real Tech Fund
331. Regeneron Pharmaceuticals
332. Regionalt Cancercentrum Stockholm-Gotland
333. RIKEN Bioresource Research Center
334. Riverside’s Highlander Venture Fund
335. Roche
336. Roswell Park Comprehensive Cancer Center
337. Rowan University
338. Rush University Medical Center
339. Samsung Medical Center
340. Sandoz
341. Sanford Burnham Prebys Medical Discovery Institute
342. Scholar Rock
343. ScreenCell
344. Seoulin Bioscience
345. Sequenom
346. Sequenta
347. Seventure Partners
348. Severance Hospital
349. Shilps Sciences
350. Shriners Hospitals for Children
351. Singapore General Hospital
352. Singapore Immunology Network
353. Singapore-MIT Alliance for Research and Technology
354. Singh Molecular Medicine
355. Singular BIO
356. Sir Charles Gairdner Hospital
357. Siwa Therapeutics
358. Skåne University Hospital
359. Sloan Kettering Institute
360. Sony Biotechnology
361. Southampton General Hospital
362. Sphere Fluidics
363. SpheriTech
364. SRI International
365. Stand Up To Cancer
366. Stanford University
367. Stanford Women's Cancer Center
368. StemBioSys
369. Stempeutics Research
370. Stony Brook University
371. Streck
372. Sumitomo Dainippon Pharma
373. Sutter Health
374. Syllogistech
375. SynGen Biotech
376. Syno Capital
377. Sysmex
378. Takeda Pharmaceutical
379. Tan Tock Seng Hospital
380. Targeted Technology Fund
381. Technical University of Denmark
382. Telegraph Hill Partners
383. Texas Stem Cell
384. The Fourth People's Hospital of Chongqing
385. Theranosis Life Sciences
386. Thermo Fisher Scientific
387. ThermoGenesis
388. ThinkCyte
389. Tisch Cancer Institute
390. Tokai Pharmaceuticals
391. TOMY Digital Biology
392. TorpedoDx
393. Tracon Pharmaceuticals
394. Trinity College Dublin
395. TumorGenesis
396. Twist Bioscience
397. Tyme
398. UCB Biopharma
399. UCLA Medical Center
400. Union Biometrica
401. United States Army Medical Research Institute for Infectious Diseases
402. United States Environmental Protection Agency
403. University of British Columbia
404. University of California
405. University of Chicago
406. University of Edinburgh
407. University of Illinois at Urbana-Champaign
408. University of Iowa Research Foundation
409. University of Kansas
410. University of Maryland
411. University of Miami
412. University of Michigan
413. University of Missouri
414. University of North Carolina
415. University of Notre Dame
416. University of Oxford John Radcliffe Hospital
417. University of Pennsylvania
418. University of Southern California Norris Comprehensive Cancer Center
419. University of Texas
420. University of Utah
421. University of Virginia School of Medicine
422. Uppsala University
423. US Department of Veterans Affairs
424. Vancouver Prostate Centre
425. Vanderbilt University
426. Vegenics
427. VentureSouth
428. Vertical Venture Partners
429. Vortex Biosciences
430. VWR
431. Wako Pure Chemical Industries
432. Washington University
433. Wego Medical Systems
434. Whitehead Institute for Biomedical Research
435. Woods Hole Oceanographic Institution
436. Wright State University
437. Xcell Biosciences
438. Yale University
439. Zeiss
440. Zhongnan Hospital of Wuhan University
441. Zomedica Pharmaceuticals
442. Zurich Instruments
443. ZymoGenetics


1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Context and Background
3.2. An Overview of Cell Sorting and Separation
3.2.1. Historical Overview
3.2.2. Basic Components and Principle of Operation
3.2.3. Cellular Characteristics for Cell Sorting and Separation
3.2.3.1. Cell Size and Shape
3.2.3.2. Cell Density and Adhesion
3.2.3.3. Hydrodynamic Properties
3.2.3.4. Polarizability, Electrical Impedance and Magnetic Susceptibility
3.2.4. Factors for Assessing the Performance of a Cell Sorter
3.2.5. Conventional Cell Sorting and Separation Technologies
3.2.5.1. Adhesion-based Sorting Method
3.2.5.2. Density Gradient Centrifugation
3.2.5.3. Membrane Filtration
3.2.5.4. Fluorescence-activated Cell Sorting
3.2.5.5. Magnetic-activated Cell Sorting
3.2.6. Limitations of Conventional Cell Sorting and Separation Methods
3.3. Novel Cell Sorting and Separation Technologies
3.3.1. Buoyancy-activated Cell Sorting
3.3.2. Microfluidics-based Cell Sorting
3.3.2.1. Active Sorting Techniques
3.3.2.1.1. Aqueous Two-Phase Sorting
3.3.2.1.2. Acoustic Sorting
3.3.2.1.3. Electrophoretic Sorting
3.3.2.1.4. Magnetophoretic Sorting
3.3.2.1.5. Optical Sorting
3.3.2.2. Passive Sorting Techniques
3.3.2.2.1. Biomimetic Sorting
3.3.2.2.2. Deterministic Lateral Displacement
3.3.2.2.3. Field Flow Fractionation
3.3.2.2.4. Gravity and Sedimentation
3.3.2.2.5. Hydrodynamic Sorting
3.3.2.2.6. Inertia-based Sorting
3.3.2.2.7. Microstructures-based Sorting
3.3.2.2.8. Microfiltration Sorting
3.3.3. Other Cell Sorting and Separation Technologies
3.3.3.1. SpheriTech Purification Technology
3.3.3.2. Traceless Affinity Cell Separation Technology
3.3.3.3. Density Difference Amplification-based Sorting
3.4. Potential Applications of Novel Cell Sorting and Separation Technologies
3.4.1. Clinical Research
3.4.2. Biomedical Diagnostics
3.4.3. Therapeutic Interventions
3.5. Growth Drivers and Roadblocks to Novel Cell Sorting and Separation Technologies
3.6. Recent Developments and Upcoming Trends
4. CURRENT MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Novel Cell Sorting Products and Solutions: Overall Market Landscape
4.2.1. Analysis by Type of Product
4.2.2. Analysis by Basis for Separation
4.2.3. Analysis by Type of Technology
4.2.4. Analysis by Cell Separation Approach
4.2.5. Analysis by Type of Cell
4.2.6 Analysis by Popular Cell Types
4.3. Novel Cell Sorting Products and Solutions: Developer Landscape
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Location of Headquarters
4.3.3. Analysis by Size of Company
4.3.4. Distribution by Type of Offering
4.3.5. Leading Developers: Analysis by Number of Products
4.3.6. Analysis by Popular Applications
4.4 Novel Cell Sorting Products and Solutions: Initiatives of Academic Players
5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Methodology
5.3. Assumptions and Key Input Parameters
5.4. Competitiveness Analysis: Overview of Novel Cell Sorting Products and Solutions Developers
5.4.1. Competitiveness Analysis: Novel Cell Sorter Developers
5.4.1.1 Cell Sorter Developers in North America
5.4.1.2. Cell Sorter Developers in Europe
5.4.1.3. Cell Sorter Developers in Asia-Pacific
5.4.2. Competitiveness Analysis: Novel Isolation Kit and Affiliated Consumable Developers
5.4.2.1 Isolation Kit and Affiliated Consumable Developers in North America
5.4.2.2. Isolation Kit and Affiliated Consumable Developers in Europe
5.4.2.3. Isolation Kit and Affiliated Consumable Developers in Asia-Pacific
6. PROFILES: COMPANIES OFFERING NOVEL CELL SORTERS / SORTING TECHNOLOGIES
6.1. Chapter Overview
6.2. NanoCellect Biomedical
6.2.1. Company Overview
6.2.2. Financial Information
6.2.3. WOLF® Cell Sorter, N1® Single Cell Dispenser: Product Description
6.2.4. Recent Developments and Future Outlook
6.3. Innovative Biochips
6.3.1. Company Overview
6.3.2 Financial Information
6.3.3. SMART ALIQUOTOR, SMART ALIQUOTOR COMPACT EDITION, SMART ALIQUOTOR EXTENDED EDITION: Product Description
6.3.4. Recent Developments and Future Outlook
6.4. Cesca Therapeutics
6.4.1. Company Overview
6.4.2. Financial Information
6.4.3. AUTOXPRESS®, CAR-TXPRESS™, CELLXPRESS™: Product Description
6.4.4. Recent Developments and Future Outlook
6.5. Fluidigm
6.5.1. Company Overview
6.5.2. Financial Information
6.5.3. C1™ System: Product Description
6.5.4. Recent Developments and Future Outlook
6.6. LumaCyte
6.6.1. Company Overview
6.6.2. Financial Information
6.6.3. Radiance™: Product Description
6.6.4. Recent Developments and Future Outlook
6.7. Union Biometrica
6.7.1. Company Overview
6.7.2. Financial Information
6.7.3. BioSorter®, COPAS™ FP: Product Description
6.7.4. Recent Developments and Future Outlook
6.8. LevitasBio
6.8.1. Company Overview
6.8.2. Financial Information
6.8.3. LeviCell System: Product Description
6.8.4. Recent Developments and Future Outlook
6.9. RareCyte®
6.9.1. Company Overview
6.9.2. Financial Information
6.9.3. AccuCyte® Sample Preparation System and CyteFinder Instruments: Product Description
6.9.4. Recent Developments and Future Outlook
6.10. Cytonome
6.10.1. Cytonome GigaSort™, Cytonome Hydris™, Cytonome Viva™: Product Description
6.10.2. Recent Developments and Future Outlook
6.11. Namocell
6.11.1. Namo™ Single Cell Dispenser, Hana™ Single Cell Dispenser: Product Description
6.11.2. Recent Developments and Future Outlook
7. PROFILES: COMPANIES OFFERING NOVEL CONSUMABLES AND ISOLATION KITS
7.1. Chapter Overview
7.2. STEMCELL Technologies
7.2.1. Company Overview
7.2.2. Financial Information
7.2.3. Product Portfolio
7.2.4. Recent Developments and Future Outlook
7.3. Akadeum Life Sciences
7.3.1. Company Overview
7.3.2. Financial Information
7.3.3. Product Portfolio
7.3.4. Recent Developments and Future Outlook
7.4. QIAGEN
7.4.1. Company Overview
7.4.2. Financial Information
7.4.3. Product Portfolio
7.4.4. Recent Developments and Future Outlook
7.5. RareCyte®
7.5.1. Company Overview
7.5.2. Financial Information
7.5.3. Product Portfolio
7.5.4. Recent Developments and Future Outlook
7.6. ScreenCell
7.6.1. Company Overview
7.6.2. Product Portfolio
7.6.3. Recent Developments and Future Outlook
8. PATENT ANALYSIS
8.1. Chapter Overview
8.2. Scope and Methodology
8.3. Novel Cell Sorting Products and Solutions: Patent Analysis
8.3.1. Analysis by Publication Year
8.3.2. Analysis by Geographical Location
8.3.3 Analysis by CPC Symbols
8.3.4. Emerging Focus Areas
8.3.5. Leading Players: Analysis by Number of Patents
8.4. Novel Cell Sorting Products and Solutions: Patent Benchmarking Analysis (Industry Players)
8.4.1. Analysis by Patent Characteristics
8.4.2. Analysis by Geographical Location
8.5. Novel Cell Sorting Products and Solutions: Patent Valuation Analysis
8.6. Leading Patents: Analysis by Number of Citations
9. PUBLICATION ANALYSIS
9.1. Chapter Overview
9.2. Scope and Methodology
9.3. Novel Cell Sorting Products and Solutions: List of Publications
9.3.1. Analysis by Year of Publication
9.3.2. Emerging Focus Areas
9.3.3. Analysis by Cell Sorting Technology
9.3.4. Analysis by Application Area
9.3.5. Analysis by Type of Cell
9.3.6. Analysis by Target Disease Indication
9.3.7. Analysis by Type of Organization Involved
9.3.8. Leading Players: Analysis by Number of Publications
9.3.9. Leading Players: Geographical Analysis by Number of Publications
9.3.10. Key Journals: Analysis by Number of Publications
10. PARTNERSHIPS AND COLLABORATIONS
10.1. Chapter Overview
10.2. Partnership Models
10.3. Novel Cell Sorting Products and Solutions: Recent Partnerships and Collaborations
10.3.1. Analysis by Year of Partnership
10.3.2. Analysis by Type of Partnership
10.3.3. Analysis by Cell Sorting Technology
10.3.4. Analysis by Type of Partner
10.3.5. Most Active Players: Analysis by Number of Partnerships
10.3.6. Geographical Analysis
10.3.6.1. Most Active Players
10.3.6.2. Intercontinental and Intracontinental Agreements
11. FUNDING AND INVESTMENT ANALYSIS
11.1. Chapter Overview
11.2. Types of Funding
11.3. Novel Cell Sorting Products and Solutions: Recent Funding Instances
11.3.1. Analysis by Number of Funding Instances
11.3.2. Analysis by Amount Invested
11.3.3. Analysis by Type of Funding
11.3.4. Analysis by Number of Funding Instances and Amount Invested across Different Cell Sorting Technologies
11.3.5. Most Active Players: Analysis by Number of Funding Instances
11.3.6. Most Active Players: Analysis by Amount Invested
11.3.7. Most Active Investors: Analysis by Number of Instances
11.3.8. Geographical Analysis by Amount Invested
11.4. Concluding Remarks
12. DEMAND ANALYSIS
12.1. Chapter Overview
12.2 Key Assumptions and Methodology
12.3. Global Demand for Novel Cell Sorting Products and Solutions, 2019-2030
12.3.1. Global Demand for Novel Cell Sorting Products and Solutions: Distribution by End Use / Application
12.3.1.1. Global Demand for Novel Cell Sorting Products and Solutions for Research Studies, 2019-2030
12.3.1.2. Global Demand for Novel Cell Sorting Products and Solutions for Clinical Diagnostics, 2019-2030
12.3.1.3. Global Demand for Novel Cell Sorting Products and Solutions for Cell-based Therapeutics, 2019-2030
12.3.1.4. Global Demand for Novel Cell Sorting Products and Solutions for Other Applications, 2019-2030
12.3.2. Global Demand for Novel Cell Sorting Products and Solutions: Distribution by Geography and End Use / Application
12.3.2.1. Demand for Novel Cell Sorting Products and Solutions in North America, 2019-2030
12.3.2.1.1. Demand for Novel Cell Sorting Products and Solutions in North America for Research Studies, 2019-2030
12.3.2.1.2. Demand for Novel Cell Sorting Products and Solutions in North America for Clinical Diagnostics, 2019-2030
12.3.2.1.3. Demand for Novel Cell Sorting Products and Solutions in North America for Cell-based Therapeutics, 2019-2030
12.3.2.1.4. Demand for Novel Cell Sorting Products and Solutions in North America for Other Applications, 2019-2030
12.3.2.2. Demand for Novel Cell Sorting Products and Solutions in Europe, 2019-2030
12.3.2.2.1. Demand for Novel Cell Sorting Products and Solutions in Europe for Research Studies, 2019-2030
12.3.2.2.2. Demand for Novel Cell Sorting Products and Solutions in Europe for Clinical Diagnostics, 2019-2030
12.3.2.2.3. Demand for Novel Cell Sorting Products and Solutions in Europe for Cell-based Therapeutics, 2019-2030
12.3.2.2.4. Demand for Novel Cell Sorting Products and Solutions in Europe for Other Applications, 2019-2030
12.3.2.3. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific, 2019-2030
12.3.2.3.1. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Research Studies, 2019-2030
12.3.2.3.2. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Clinical Diagnostics, 2019-2030
12.3.2.3.3. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Cell-based Therapeutics, 2019-2030
12.3.2.3.4. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Other Applications, 2019-2030
13. MARKET FORECAST
13.1. Chapter Overview
13.2. Key Assumptions and Forecast Methodology
13.3. Overall Novel Cell Sorting Products and Solutions Market
13.3.1. Overall Novel Cell Sorting Products and Solutions Market, 2019-2030 (By Value)
13.3.2 Overall Novel Cell Sorting Products and Solutions Market, 2019-2030 (By Volume)
13.4. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Offering
13.4.1. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Offering, 2019-2030 (By Value)
13.4.1.1. Novel Cell Sorting Products and Solutions Market for Cell Sorters, 2019-2030 (By Value)
13.4.1.2. Novel Cell Sorting Products and Solutions Market for Consumables and Isolation Kits, 2019-2030 (By Value)
13.5. Overall Novel Cell Sorting Products and Solutions Market: Distribution by End Use / Application
13.5.1. Overall Novel Cell Sorting Products and Solutions Market: Distribution by End Use / Application, 2019-2030 (By Value)
13.5.1.1. Novel Cell Sorting Products and Solutions Market for Research Studies, 2019-2030 (By Value)
13.5.1.2. Novel Cell Sorting Products and Solutions Market for Clinical Diagnostics, 2019-2030 (By Value)
13.5.1.3. Novel Cell Sorting Products and Solutions Market for Cell-based Therapeutics, 2019-2030 (By Value)
13.5.1.4. Novel Cell Sorting Products and Solutions Market for Other Applications, 2019-2030 (By Value)
13.5.2. Overall Novel Cell Products and Solutions Market: Distribution by End Use / Application, 2019-2030 (By Volume)
13.5.2.1. Novel Cell Sorting Products and Solutions Market for Research Studies, 2019-2030 (By Volume)
13.5.2.2. Novel Cell Sorting Products and Solutions Market for Clinical Diagnostics, 2019-2030 (By Volume)
13.5.2.3. Novel Cell Sorting Products and Solutions Market for Cell-based Therapeutics, 2019-2030 (By Volume)
13.5.2.4. Novel Cell Sorting Products and Solutions Market for Other Applications, 2019-2030 (By Volume)
13.6. Overall Novel Cell Sorting Products and Solutions Market: Distribution by End User
13.6.1. Overall Novel Cell Sorting Products and Solutions Market: Distribution by End User, 2019-2030 (By Value)
13.6.1.1. Novel Cell Sorting Products and Solutions Market for Academic Institutes, 2019-2030 (By Value)
13.6.1.2. Novel Cell Sorting Products and Solutions Market for Clinical Testing Labs, 2019-2030 (By Value)
13.6.1.3. Novel Cell Sorting Products and Solutions Market for Commercial Organizations, 2019-2030 (By Value)
13.6.1.4. Novel Cell Sorting Products and Solutions Market for Hospitals, 2019-2030 (By Value)
13.6.2. Overall Novel Cell Products and Solutions Market: Distribution by End User, 2019-2030 (By Volume)
13.6.2.1. Novel Cell Sorting Products and Solutions Market for Academic Institutes, 2019-2030 (By Volume)
13.6.2.2. Novel Cell Sorting Products and Solutions Market for Clinical Testing Labs, 2019-2030 (By Volume)
13.6.2.3. Novel Cell Sorting Products and Solutions Market for Commercial Organizations, 2019-2030 (By Volume)
13.6.2.4. Novel Cell Sorting Products and Solutions Market for Hospitals, 2019-2030 (By Volume)
13.7. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Cell Sorting Technology
13.7.1. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Cell Sorting Technology, 2019-2030 (By Value)
13.7.1.1. Novel Cell Sorting Products and Solutions Market for Buoyancy-activated, 2019-2030 (By Value)
13.7.1.2. Novel Cell Sorting Products and Solutions Market for Magnetophoretics, 2019-2030 (By Value)
13.7.1.3. Novel Cell Sorting Products and Solutions Market for Microfluidics, 2019-2030 (By Value)
13.7.1.4. Novel Cell Sorting Products and Solutions Market for Optoelectronics, 2019-2030 (By Value)
13.7.1.5. Novel Cell Sorting Products and Solutions Market for Other Advanced Technologies, 2019-2030 (By Value)
13.7.2. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Cell Sorting Technology, 2019-2030 (By Volume)
13.7.2.1. Novel Cell Sorting Products and Solutions Market for Buoyancy-activated, 2019-2030 (By Volume)
13.7.2.2. Novel Cell Sorting Products and Solutions Market for Magnetophoretics, 2019-2030 (By Volume)
13.7.2.3. Novel Cell Sorting Products and Solutions Market for Microfluidics, 2019-2030 (By Volume)
13.7.2.4. Novel Cell Sorting Products and Solutions Market for Optoelectronics, 2019-2030 (By Volume)
13.7.2.5. Novel Cell Sorting Products and Solutions Market for Other Advanced Technologies, 2019-2030 (By Volume)
13.8. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Cell
13.8.1. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Cell, 2019-2030 (By Value)
13.8.1.1. Novel Cell Sorting Products and Solutions Market for Adult Stem Cells, 2019-2030 (By Value)
13.8.1.2. Novel Cell Sorting Products and Solutions Market for CAR-T Cells, 2019-2030 (By Value)
13.8.1.3. Novel Cell Sorting Products and Solutions Market for Circulating Fetal Cells, 2019-2030 (By Value)
13.8.1.4. Novel Cell Sorting Products and Solutions Market for Circulating Tumor Cells, 2019-2030 (By Value)
13.8.1.5. Novel Cell Sorting Products and Solutions Market for Dendritic Cells, 2019-2030 (By Value)
13.8.1.6. Novel Cell Sorting Products and Solutions Market for Embryonic Stem Cells, 2019-2030 (By Value)
13.8.1.7. Novel Cell Sorting Products and Solutions Market for Insect Cells, 2019-2030 (By Value)
13.8.1.8. Novel Cell Sorting Products and Solutions Market for Induced Pluripotent Stem Cells, 2019-2030 (By Value)
13.8.1.9. Novel Cell Sorting Products and Solutions Market for Microbial Cells, 2019-2030 (By Value)
13.8.1.10. Novel Cell Sorting Products and Solutions Market for Sperm Cells, 2019-2030 (By Value)
13.8.1.11. Novel Cell Sorting Products and Solutions Market for TCR Cells, 2019-2030 (By Value)
13.8.1.12. Novel Cell Sorting Products and Solutions Market for TIL Cells, 2019-2030 (By Value)
13.8.1.13. Novel Cell Sorting Products and Solutions Market for Tumor / Cancer Cells, 2019-2030 (By Value)
13.8.2. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Cell, 2019-2030 (By Volume)
13.8.2.1. Novel Cell Sorting Products and Solutions Market for Adult Stem Cells, 2019-2030 (By Volume)
13.8.2.2. Novel Cell Sorting Products and Solutions Market for CAR-T Cells, 2019-2030 (By Volume)
13.8.2.3. Novel Cell Sorting Products and Solutions Market for Circulating Fetal Cells, 2019-2030 (By Volume)
13.8.2.4. Novel Cell Sorting Products and Solutions Market for Circulating Tumor Cells, 2019-2030 (By Volume)
13.8.2.5. Novel Cell Sorting Products and Solutions Market for Dendritic Cells, 2019-2030 (By Volume)
13.8.2.6. Novel Cell Sorting Products and Solutions Market for Embryonic Stem Cells, 2019-2030 (By Volume)
13.8.2.7. Novel Cell Sorting Products and Solutions Market for Insect Cells, 2019-2030 (By Volume)
13.8.2.8. Novel Cell Sorting Products and Solutions Market for Induced Pluripotent Stem Cells, 2019-2030 (By Volume)
13.8.2.9. Novel Cell Sorting Products and Solutions Market for Microbial Cells, 2019-2030 (By Volume)
13.8.2.10. Novel Cell Sorting Products and Solutions Market for Sperm Cells, 2019-2030 (By Volume)
13.8.2.11. Novel Cell Sorting Products and Solutions Market for TCR Cells, 2019-2030 (By Volume)
13.8.2.12. Novel Cell Sorting Products and Solutions Market for TIL Cells, 2019-2030 (By Volume)
13.8.2.13. Novel Cell Sorting Products and Solutions Market for Tumor / Cancer Cells, 2019-2030 (By Volume)
13.9. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Size of Cell
13.9.1. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Size of Cell, 2019-2030 (By Value)
13.9.1.1. Novel Cell Sorting Products and Solutions Market for Less Than 5 µm Cell Size, 2019-2030 (By Value)
13.9.1.2. Novel Cell Sorting Products and Solutions Market for 5-10 µm Cell Size, 2019-2030 (By Value)
13.9.1.3. Novel Cell Sorting Products and Solutions Market for 10-15 µm Cell Size, 2019-2030 (By Value)
13.9.1.4. Novel Cell Sorting Products and Solutions Market for 15-25 µm Cell Size, 2019-2030 (By Value)
13.9.1.5. Novel Cell Sorting Products and Solutions Market for Greater Than 25 µm Cell Size, 2019-2030 (By Value)
13.9.2. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Size of Cell, 2019-2030 (By Volume)
13.9.2.1. Novel Cell Sorting Products and Solutions Market for Less Than 5 µm Cell Size, 2019-2030 (By Volume)
13.9.2.2. Novel Cell Sorting Products and Solutions Market for 5-10 µm Cell Size, 2019-2030 (By Volume)
13.9.2.3. Novel Cell Sorting Products and Solutions Market for 10-15 µm Cell Size, 2019-2030 (By Volume)
13.9.2.4. Novel Cell Sorting Products and Solutions Market for 15-25 µm Cell Size, 2019-2030 (By Volume)
13.9.2.5. Novel Cell Sorting Products and Solutions Market for Greater Than 25 µm Cell Size, 2019-2030 (By Volume)
13.10. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Geography
13.10.1. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Geography, 2019-2030 (By Value)
13.10.1.1. Novel Cell Sorting Products and Solutions Market in North America, 2019-2030 (By Value)
13.10.1.2. Novel Cell Sorting Products and Solutions Market in Europe, 2019-2030 (By Value)
13.10.1.3 Novel Cell Sorting Products and Solutions Market in Asia-Pacific, 2019-2030 (By Value)
13.10.2. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Geography, 2019-2030 (By Volume)
13.10.2.1. Novel Cell Sorting Products and Solutions Market in North America, 2019-2030 (By Volume)
13.10.2.2. Novel Cell Sorting Products and Solutions Market in Europe, 2019-2030 (By Volume)
13.10.2.3. Novel Cell Sorting Products and Solutions Market in Asia-Pacific, 2019-2030 (By Volume)
13.11. Overall Novel Cell Sorting Products and Solutions Market: Distribution by End Use / Application, Cell Sorting Technology and Type of Offering
13.11.1. Overall Novel Cell Sorting Products and Solutions Market for Research Studies: Distribution by Cell Sorting Technology and Type of Offering (By Value)
13.11.1.1. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Research Studies, 2019-2030 (By Value)
13.11.1.1.1. Buoyancy-activated Cell Sorters Market for Research Studies, 2019-2030 (By Value)
13.11.1.1.2. Buoyancy-activated Consumables and Isolation Kits Market for Research Studies, 2019-2030 (By Value)
13.11.1.2. Novel Cell Sorting Market for Magnetophoretics-based Products and Solutions for Research Studies, 2019-2030 (By Value)
13.11.1.2.1. Magnetophoretics-based Cell Sorters Market for Research Studies, 2019-2030 (By Value)
13.11.1.2.2. Magnetophoretics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (By Value)
13.11.1.3. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Research Studies, 2019-2030 (By Value)
13.11.1.3.1. Microfluidics-based Cell Sorters Market for Research Studies, 2019-2030 (By Value)
13.11.1.3.2. Microfluidics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (By Value)
13.11.1.4. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Research Studies, 2019-2030 (By Value)
13.11.1.4.1. Optoelectronics-based Cell Sorters Market for Research Studies, 2019-2030 (By Value)
13.11.1.4.2. Optoelectronics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (By Value)
13.11.1.5. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Research Studies, 2019-2030 (By Value)
13.11.1.5.1. Other Advanced Technologies-based Cell Sorters Market for Research Studies, 2019-2030 (By Value)
13.11.1.5.2. Other Advanced Technologies-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (By Value)
13.11.2. Overall Novel Cell Sorting Products and Solutions Market for Research Studies: Distribution by Cell Sorting Technology (By Volume)
13.11.2.1. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Research Studies, 2019-2030 (By Volume)
13.11.2.2. Novel Cell Sorting Market for Magnetophoretics-based Products and Solutions for Research Studies, 2019-2030 (By Volume)
13.11.2.3. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Research Studies, 2019-2030 (By Volume)
13.11.2.4. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Research Studies, 2019-2030 (By Volume)
13.11.2.5. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Research Studies, 2019-2030 (By Volume)
13.11.3. Overall Novel Cell Sorting Products and Solutions Market for Clinical Diagnostics: Distribution by Cell Sorting Technology and Type of Offering (By Value)
13.11.3.1. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Clinical Diagnostics, 2019-2030 (By Value)
13.11.3.1.1. Buoyancy-activated Cell Sorters Market for Clinical Diagnostics, 2019-2030 (By Value)
13.11.3.1.2. Buoyancy-activated Consumables and Isolation Kits Market for Clinical Diagnostics, 2019-2030 (By Value)
13.11.3.2. Novel Cell Sorting Market for Magnetophoretics-based Products and Solutions for Clinical Diagnostics, 2019-2030 (By Value)
13.11.3.2.1. Magnetophoretics-based Cell Sorters Market for Clinical Diagnostics, 2019-2030 (By Value)
13.11.3.2.2. Magnetophoretics-based Consumables and Isolation Kits Market for Clinical Diagnostics, 2019-2030 (By Value)
13.11.3.3. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Clinical Diagnostics, 2019-2030 (By Value)
13.11.3.3.1. Microfluidics-based Cell Sorters Market for Clinical Diagnostics, 2019-2030 (By Value)
13.11.3.3.2. Microfluidics-based Consumables and Isolation Kits Market for Clinical Diagnostics, 2019-2030 (By Value)
13.11.3.4. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Clinical Diagnostics, 2019-2030 (By Value)
13.11.3.4.1. Optoelectronics-based Cell Sorters Market for Clinical Diagnostics, 2019-2030 (By Value)
13.11.3.4.2. Optoelectronics-based Consumables and Isolation Kits Market for Clinical Diagnostics, 2019-2030 (By Value)
13.11.3.5. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Clinical Diagnostics, 2019-2030 (By Value)
13.11.3.5.1. Other Advanced Technologies-based Cell Sorters Market for Clinical Diagnostics, 2019-2030 (By Value)
13.11.3.5.2. Other Advanced Technologies-based Consumables and Isolation Kits Market for Clinical Diagnostics, 2019-2030 (By Value)
13.11.4. Overall Novel Cell Sorting Products and Solutions Market for Clinical Diagnostics: Distribution by Cell Sorting Technology (By Volume)
13.11.4.1. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Clinical Diagnostics, 2019-2030 (By Volume)
13.11.4.2. Novel Cell Sorting Market for Magnetophoretics-based Products and Solutions for Clinical Diagnostics, 2019-2030 (By Volume)
13.11.4.3. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Clinical Diagnostics, 2019-2030 (By Volume)
13.11.4.4. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Clinical Diagnostics, 2019-2030 (By Volume)
13.11.4.5. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Clinical Diagnostics, 2019-2030 (By Volume)
13.11.5. Overall Novel Cell Sorting Products and Solutions Market for Cell-based Therapeutics: Distribution by Cell Sorting Technology and Type of Offering (By Value)
13.11.5.1. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Cell-based Therapeutics, 2019-2030 (By Value)
13.11.5.1.1. Buoyancy-activated Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (By Value)
13.11.5.1.2. Buoyancy-activated Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (By Value)
13.11.5.2. Novel Cell Sorting Market for Magnetophoretics-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (By Value)
13.11.5.2.1. Magnetophoretics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (By Value)
13.11.5.2.2. Magnetophoretics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (By Value)
13.11.5.3. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (By Value)
13.11.5.3.1. Microfluidics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (By Value)
13.11.5.3.2. Microfluidics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (By Value)
13.11.5.4. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (By Value)
13.11.5.4.1. Optoelectronics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (By Value)
13.11.5.4.2. Optoelectronics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (By Value)
13.11.5.5. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (By Value)
13.11.5.5.1. Other Advanced Technologies-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (By Value)
13.11.5.5.2. Other Advanced Technologies-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (By Value)
13.11.6. Overall Novel Cell Sorting Products and Solutions Market for Cell-based Therapeutics: Distribution by Cell Sorting Technology (By Volume)
13.11.6.1. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Cell-based Therapeutics, 2019-2030 (By Volume)
13.11.6.2. Novel Cell Sorting Market for Magnetophoretics-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (By Volume)
13.11.6.3. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (By Volume)
13.11.6.4. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (By Volume)
13.11.6.5. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (By Volume)
13.11.7. Overall Novel Cell Sorting Products and Solutions Market for Other Applications: Distribution by Cell Sorting Technology and Type of Offering (By Value)
13.11.7.1. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Other Applications, 2019-2030 (By Value)
13.11.7.1.1. Buoyancy-activated Cell Sorters Market for Other Applications, 2019-2030 (By Value)
13.11.7.1.2. Buoyancy-activated Consumables and Isolation Kits Market for Other Applications, 2019-2030 (By Value)
13.11.7.2. Novel Cell Sorting Market for Magnetophoretics-based Products and Solutions for Other Applications, 2019-2030 (By Value)
13.11.7.2.1. Magnetophoretics-based Cell Sorters Market for Other Applications, 2019-2030 (By Value)
13.11.7.2.2. Magnetophoretics-based Consumables and Isolation Kits Market for Other Applications, 2019-2030 (By Value)
13.11.7.3. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Other Applications, 2019-2030 (By Value)
13.11.7.3.1. Microfluidics-based Cell Sorters Market for Other Applications, 2019-2030 (By Value)
13.11.7.3.2. Microfluidics-based Consumables and Isolation Kits Market for Other Applications, 2019-2030 (By Value)
13.11.7.4. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Other Applications, 2019-2030 (By Value)
13.11.7.4.1. Optoelectronics-based Cell Sorters Market for Other Applications, 2019-2030 (By Value)
13.11.7.4.2. Optoelectronics-based Consumables and Isolation Kits Market for Other Applications, 2019-2030 (By Value)
13.11.7.5. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Other Applications, 2019-2030 (By Value)
13.11.7.5.1. Other Advanced Technologies-based Cell Sorters Market for Other Applications, 2019-2030 (By Value)
13.11.7.5.2. Other Advanced Technologies-based Consumables and Isolation Kits Market for Other Applications, 2019-2030 (By Value)
13.11.8. Overall Novel Cell Sorting Products and Solutions Market for Other Applications: Distribution by Cell Sorting Technology (By Volume)
13.11.8.1. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Other Applications, 2019-2030 (By Volume)
13.11.8.2. Novel Cell Sorting Market for Magnetophoretics-based Products and Solutions for Other Applications, 2019-2030 (By Volume)
13.11.8.3. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Other Applications, 2019-2030 (By Volume)
13.11.8.4. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Other Applications, 2019-2030 (By Volume)
13.11.8.5. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Other Applications, 2019-2030 (By Volume)
14. EXECUTIVE INSIGHTS
14.1. Chapter Overview
14.2. Akadeum Life Sciences
14.2.1. Company Snapshot
14.2.2. Interview Transcript: John Younger, Co-founder and Chief Technology Officer
14.3. LumaCyte
14.3.1. Company Snapshot
14.3.2. Interview Transcript: Sean Hart, Chief Executive Officer and Chief Scientific Officer
14.4. Namocell
14.4.1. Company Snapshot
14.4.2. Interview Transcript: Soohee Cho, Product Manager
15. CONCLUDING REMARKS
15.1. Chapter Overview
15.2. Key Takeaways
16. APPENDIX 1: TABULATED DATA
17. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
LIST OF FIGURES
Figure 3.1 Basic Components of a Cell Sorter
Figure 3.2 Limitations of Conventional Cell Sorting and Separation Methods
Figure 3.3 Classification of Novel Cell Sorting and Separation Technologies
Figure 3.4 Advantages and Challenges of Buoyancy-activated Cell Sorting
Figure 3.5 Advantages and Challenges of Microfluidics-based Cell Sorting
Figure 3.6 Potential Applications of Novel Cell Sorting and Separation Technologies
Figure 3.7 Growth Drivers and Roadblocks to Novel Cell Sorting and Separation Technologies
Figure 3.8 Development Journey of Novel Cell Sorting and Separation Technologies
Figure 4.1 Novel Cell Sorting Products and Solutions: Distribution by Type of Product
Figure 4.2 Novel Cell Sorting Products and Solutions: Distribution by Basis for Separation
Figure 4.3 Novel Cell Sorting Products and Solutions: Distribution by Type of Technology
Figure 4.4 Novel Cell Sorting Products and Solutions: Developer Landscape by Type of Technology
Figure 4.5 Novel Cell Sorting Products and Solutions: Distribution by Cell Separation Approach
Figure 4.6 Novel Cell Sorting Products and Solutions: Distribution by Type of Cells
Figure 4.7 Novel Cell Sorting Products and Solutions: Distribution by Type of Technology and Type of Cell
Figure 4.8 Novel Cell Sorting Products and Solutions: Geographical Landscape of Developers by Type of Cell
Figure 4.9 Novel Cell Sorting Products and Solutions: Popular Cell Types
Figure 4.10 Novel Cell Sorting Products and Solutions: Distribution of Industry Players by Year of Establishment
Figure 4.11 Novel Cell Sorting Products and Solutions: Distribution of Industry Players by Geographical Location
Figure 4.12 Novel Cell Sorting Products and Solutions: Distribution of Industry Players by Size (Employee Count)
Figure 4.13 Novel Cell Sorting Products and Solutions: Distribution of Industry Players by Type of Offering
Figure 4.14 Leading Developers: Distribution by Number of Novel Cell Sorting Products and Solutions
Figure 4.15 Novel Cell Sorting Products and Solutions: Popular Applications
Figure 4.16 Grid Analysis: Distribution by Company Size, Type of Offering and End Use / Application
Figure 5.1 Competitiveness Analysis of Novel Cell Sorting Product Developers Located across the Globe
Figure 5.2 Competitiveness Analysis of Novel Cell Sorter Developers in North America
Figure 5.3 Competitiveness Analysis of Novel Cell Sorter Developers in Europe
Figure 5.4 Competitiveness Analysis of Novel Cell Sorter Developers in Asia-Pacific
Figure 5.5 Competitiveness Analysis of Novel Isolation Kit and Affiliated Consumable Developers in North America
Figure 5.6 Competitiveness Analysis of Novel Isolation Kit and Affiliated Consumable Developers in Europe
Figure 5.7 Competitiveness Analysis of Novel Isolation Kit and Affiliated Consumable Developers in Asia-Pacific
Figure 6.1 Cesca Therapeutics: Net Revenues, FY 2014-H1 FY 2019 (USD Million)
Figure 6.2 Cesca Therapeutics: Distribution of Net Revenues by Business Segment, FY 2018 (USD Million)
Figure 6.3 Cesca Therapeutics: Distribution of Net Revenues by Products Offered in Device Segment, FY 2018 (USD Million)
Figure 6.4 Cesca Therapeutics: Distribution of Net Revenues by Region, FY 2018 (USD Million)
Figure 6.5 Fluidigm: Net Revenues, FY 2014-HI FY 2019 (USD Million)
Figure 6.6 Fluidigm: Distribution of Net Revenues by Type of Offering, FY 2018 (USD Million)
Figure 6.7 Fluidigm: Distribution of Net Revenues by Region, FY 2018 (USD Million)
Figure 7.1 QIAGEN: Net Sales, FY 2014-H1 FY 2019 (USD Million)
Figure 7.2 QIAGEN: Distribution of Net Sales by Product Segments, FY 2018 (USD Million)
Figure 7.3 QIAGEN: Distribution of Net Sales by Customer Segments, FY 2018 (USD Million)
Figure 7.4 QIAGEN: Distribution of Net Sales by Region, FY 2018 (USD Million)
Figure 8.1 Patent Analysis: Distribution by Type
Figure 8.2 Patent Analysis: Cumulative Year-wise Trend, 2014-2018
Figure 8.3 Patent Analysis: Distribution by Geographical Location
Figure 8.4 Patent Analysis: Distribution by CPC Symbols (Top 20)
Figure 8.5 Patent Analysis: Emerging Focus Areas
Figure 8.6 Most Active Industry Players: Distribution by Number of Patents
Figure 8.7 Most Active Non-Industry Players: Distribution by Number of Patents
Figure 8.8 Patent Analysis: Benchmarking by Patent Characteristics
Figure 8.9 Patent Analysis: Benchmarking by Number of Patents Published across Different Geographies
Figure 8.10 Patent Analysis: Benchmarking by Number of International and Local Patents
Figure 8.11 Patent Analysis: Distribution by Patent Age
Figure 8.12 Patent Analysis: Distribution by Geography and Publication Year, 2014-2018
Figure 8.13 Patent Analysis: Distribution by Relative Valuation
Figure 9.1 Publication Analysis: Cumulative Year-wise Trend, 2014-2018
Figure 9.2 Publication Analysis: Emerging Focus Areas
Figure 9.3 Publication Analysis: Distribution by Cell Sorting Technology
Figure 9.4 Publication Analysis: Distribution by End Use / Application Area
Figure 9.5 Publication Analysis: Distribution by Type of Cell
Figure 9.6 Publication Analysis: Distribution by Target Disease Indication
Figure 9.7 Publication Analysis: Distribution by Type of Organization Involved
Figure 9.8 Most Active Players: Distribution by Number of Publications
Figure 9.9 Most Active Players: Geographical Distribution by Number of Publications
Figure 9.10 Key Journals: Distribution by Number of Publications
Figure 10.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2014-Q1 2019
Figure 10.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 10.3 Partnerships and Collaborations: Year-wise Trend by Type of Partnership
Figure 10.4 Partnerships and Collaborations: Distribution by Cell Sorting Technology
Figure 10.5 Partnerships and Collaborations: Year-wise Trend by Cell Sorting Technology
Figure 10.6 Partnerships and Collaborations: Distribution by Type of Partner
Figure 10.7 Most Active Players: Distribution by Number of Partnerships
Figure 10.8 Most Active Players: Geographical Distribution by Number of Partnerships
Figure 10.9 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 11.1 Funding and Investments: Distribution of Industry Players by Year of Establishment and Type of Funding, 2014-Q1 2019
Figure 11.2 Funding and Investments: Distribution of Amount Invested by Focus Area and Type of Funding, 2014-Q1 2019
Figure 11.3 Funding and Investments: Cumulative Year-wise Trend, 2014-Q1 2019
Figure 11.4 Funding and Investments: Cumulative Amount Invested by Year, 2014-Q1 2019 (USD Million)
Figure 11.5 Funding and Investments: Distribution by Type of Funding
Figure 11.6 Funding and Investments: Distribution by Amount Invested and Type of Funding (USD Million)
Figure 11.7 Funding and Investments: Summary of Investments, 2014-Q1 2019 (USD Million)
Figure 11.8 Popular Cell Sorting Technologies: Distribution by Number of Funding Instances
Figure 11.9 Popular Cell Sorting Technologies: Distribution by Amount Invested (USD Million)
Figure 11.10 Funding and Investments: Year-wise Trend of Amount Invested across Different Cell Sorting Technologies, 2014-Q1 2019 (USD Million)
Figure 11.11 Most Active Players: Distribution by Number of Instances
Figure 11.12 Most Active Players: Distribution by Amount Raised (USD Million)
Figure 11.13 Most Active Investors: Distribution by Number of Instances
Figure 11.14 Funding and Investments: Geographical Distribution by Amount Invested (USD Million)
Figure 11.15 Funding and Investments: Funding and Investment Summary
Figure 12.1 Global Demand for Novel Cell Sorting Products and Solutions, 2019-2030 (Million Unit Operations / Processes)
Figure 12.2 Global Demand for Novel Cell Sorting Products and Solutions: Distribution by End Use / Application, 2019 and 2030
Figure 12.3 Global Demand for Novel Cell Sorting Products and Solutions for Research Studies, 2019-2030 (Million Projects)
Figure 12.4 Global Demand for Novel Cell Sorting Products and Solutions for Clinical Diagnostics, 2019-2030 (Million Tests)
Figure 12.5 Global Demand for Novel Cell Sorting Products and Solutions for Cell-based Therapeutics, 2019-2030 (Million Therapy Products)
Figure 12.6 Global Demand for Novel Cell Sorting Products and Solutions for Other Applications, 2019-2030 (Million Treatment Procedures)
Figure 12.7 Global Demand for Novel Cell Sorting Products and Solutions: Distribution by Geography, 2019 and 2030
Figure 12.8 Demand for Novel Cell Sorting Products and Solutions in North America, 2019-2030 (Million Unit Operations / Processes)
Figure 12.9 Demand for Novel Cell Sorting Products and Solutions in North America for Research Studies, 2019-2030 (Million Projects)
Figure 12.10 Demand for Novel Cell Sorting Products and Solutions in North America for Clinical Diagnostics, 2019-2030 (Million Tests)
Figure 12.11 Demand for Novel Cell Sorting Products and Solutions in North America for Cell-based Therapeutics, 2019-2030 (Million Therapy Products)
Figure 12.12 Demand for Novel Cell Sorting Products and Solutions in North America for Other Applications, 2019-2030 (Million Treatment Procedures)
Figure 12.13 Demand for Novel Cell Sorting Products and Solutions in Europe, 2019-2030 (Million Unit Operations / Processes)
Figure 12.14 Demand for Novel Cell Sorting Products and Solutions in Europe for Research Studies, 2019-2030 (Million Projects)
Figure 12.15 Demand for Novel Cell Sorting Products and Solutions in Europe for Clinical Diagnostics, 2019-2030 (Million Tests)
Figure 12.16 Demand for Novel Cell Sorting Products and Solutions in Europe for Cell-based Therapeutics, 2019-2030 (Million Therapy Products)
Figure 12.17 Demand for Novel Cell Sorting Products and Solutions in Europe for Other Applications, 2019-2030 (Million Treatment Procedures)
Figure 12.18 Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific, 2019-2030 (Million Unit Operations / Processes)
Figure 12.19 Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Research Studies, 2019-2030 (Million Projects)
Figure 12.20 Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Clinical Diagnostics, 2019-2030 (Million Tests)
Figure 12.21 Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Cell-based Therapeutics, 2019-2030 (Million Therapy Products)
Figure 12.22 Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Other Applications, 2019-2030 (Million Treatment Procedures)
Figure 13.1 Novel Cell Sorting Products and Solutions: Current and Estimated Market Share, 2019 and 2030
Figure 13.2 Breakdown of a Bioprocess by Unit Operations: Overall Cost of Goods and Cell Separation / Purification Costs
Figure 13.3 Overall Novel Cell Sorting Products and Solutions Market, 2019-2030 (USD Million)
Figure 13.4 Overall Novel Cell Sorting Products and Solutions Market, 2019-2030 (Million Unit Operations / Processes)
Figure 13.5 Novel Cell Sorting Products and Solutions Market for Cell Sorters, 2019-2030 (USD Million)
Figure 13.6 Novel Cell Sorting Products and Solutions Market for Consumables and Isolation Kits, 2019-2030 (USD Million)
Figure 13.7 Novel Cell Sorting Products and Solutions Market for Research Studies, 2019-2030 (USD Million)
Figure 13.8 Novel Cell Sorting Products and Solutions Market for Clinical Diagnostics, 2019-2030 (USD Million)
Figure 13.9 Novel Cell Sorting Products and Solutions Market for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 13.10 Novel Cell Sorting Products and Solutions Market for Other Applications, 2019-2030 (USD Million)
Figure 13.11 Novel Cell Sorting Products and Solutions Market for Research Studies, 2019-2030 (Million Projects)
Figure 13.12 Novel Cell Sorting Products and Solutions Market for Clinical Diagnostics, 2019-2030 (Million Tests)
Figure 13.13 Novel Cell Sorting Products and Solutions Market for Cell-based Therapeutics, 2019-2030 (Million Therapy Products)
Figure 13.14 Novel Cell Sorting Products and Solutions Market for Other Applications, 2019-2030 (Million Treatment Procedures)
Figure 13.15 Novel Cell Sorting Products and Solutions Market for Academic Institutes, 2019-2030 (USD Million)
Figure 13.16 Novel Cell Sorting Products and Solutions Market for Clinical Testing Labs, 2019-2030 (USD Million)
Figure 13.17 Novel Cell Sorting Products and Solutions Market for Commercial Organizations, 2019-2030 (USD Million)
Figure 13.18 Novel Cell Sorting Products and Solutions Market for Hospitals, 2019-2030 (USD Million)
Figure 13.19 Novel Cell Sorting Products and Solutions Market for Academic Institutes, 2019-2030 (Million Unit Operations / Processes)
Figure 13.20 Novel Cell Sorting Products and Solutions Market for Clinical Testing Labs, 2019-2030 (Million Unit Operations / Processes)
Figure 13.21 Novel Cell Sorting Products and Solutions Market for Commercial Organizations, 2019-2030 (Million Unit Operations / Processes)
Figure 13.22 Novel Cell Sorting Products and Solutions Market for Hospitals, 2019-2030 (Million Unit Operations / Processes)
Figure 13.23 Novel Cell Sorting Products and Solutions Market for Buoyancy-activated, 2019-2030 (USD Million)
Figure 13.24 Novel Cell Sorting Products and Solutions Market for Magnetophoretics, 2019-2030 (USD Million)
Figure 13.25 Novel Cell Sorting Products and Solutions Market for Microfluidics, 2019-2030 (USD Million)
Figure 13.26 Novel Cell Sorting Products and Solutions Market for Optoelectronics, 2019-2030 (USD Million)
Figure 13.27 Novel Cell Sorting Products and Solutions Market for Other Advanced Technologies, 2019-2030 (USD Million)
Figure 13.28 Novel Cell Sorting Products and Solutions Market for Buoyancy-activated, 2019-2030 (Million Unit Operations / Processes)
Figure 13.29 Novel Cell Sorting Products and Solutions Market for Magnetophoretics, 2019-2030 (Million Unit Operations / Processes)
Figure 13.30 Novel Cell Sorting Products and Solutions Market for Microfluidics, 2019-2030 (Million Unit Operations / Processes)
Figure 13.31 Novel Cell Sorting Products and Solutions Market for Optoelectronics, 2019-2030 (Million Unit Operations / Processes)
Figure 13.32 Novel Cell Sorting Products and Solutions Market for Other Advanced Technologies, 2019-2030 (Million Unit Operations / Processes)
Figure 13.33 Novel Cell Sorting Products and Solutions Market for Adult Stem Cells, 2019-2030 (USD Million)
Figure 13.34 Novel Cell Sorting Products and Solutions Market for CAR-T Cells, 2019-2030 (USD Million)
Figure 13.35 Novel Cell Sorting Products and Solutions Market for Circulating Fetal Cells, 2019-2030 (USD Million)
Figure 13.36 Novel Cell Sorting Products and Solutions Market for Circulating Tumor Cells, 2019-2030 (USD Million)
Figure 13.37 Novel Cell Sorting Products and Solutions Market for Dendritic Cells, 2019-2030 (USD Million)
Figure 13.38 Novel Cell Sorting Products and Solutions Market for Embryonic Stem Cells, 2019-2030 (USD Million)
Figure 13.39 Novel Cell Sorting Products and Solutions Market for Insect Cells, 2019-2030 (USD Million)
Figure 13.40 Novel Cell Sorting Products and Solutions Market for Induced Pluripotent Stem Cells, 2019-2030 (USD Million)
Figure 13.41 Novel Cell Sorting Products and Solutions Market for Microbial Cells, 2019-2030 (USD Million)
Figure 13.42 Novel Cell Sorting Products and Solutions Market for Sperm Cells, 2019-2030 (USD Million)
Figure 13.43 Novel Cell Sorting Products and Solutions Market for TCR Cells, 2019-2030 (USD Million)
Figure 13.44 Novel Cell Sorting Products and Solutions Market for TIL Cells, 2019-2030 (USD Million)
Figure 13.45 Novel Cell Sorting Products and Solutions Market for Tumor / Cancer Cells, 2019-2030 (USD Million)
Figure 13.46 Novel Cell Sorting Products and Solutions Market for Adult Stem Cells, 2019-2030 (Million Unit Operations / Processes)
Figure 13.47 Novel Cell Sorting Products and Solutions Market for CAR-T Cells, 2019-2030 (Million Unit Operations / Processes)
Figure 13.48 Novel Cell Sorting Products and Solutions Market for Circulating Fetal Cells, 2019-2030 (Million Unit Operations / Processes)
Figure 13.49 Novel Cell Sorting Products and Solutions Market for Circulating Tumor Cells, 2019-2030 (Million Unit Operations / Processes)
Figure 13.50 Novel Cell Sorting Products and Solutions Market for Dendritic Cells, 2019-2030 (Million Unit Operations / Processes)
Figure 13.51 Novel Cell Sorting Products and Solutions Market for Embryonic Stem Cells, 2019-2030 (Million Unit Operations / Processes)
Figure 13.52 Novel Cell Sorting Products and Solutions Market for Insect Cells, 2019-2030 (Million Unit Operations / Processes)
Figure 13.53 Novel Cell Sorting Products and Solutions Market for Induced Pluripotent Stem Cells, 2019-2030 (Million Unit Operations / Processes)
Figure 13.54 Novel Cell Sorting Products and Solutions Market for Microbial Cells, 2019-2030 (Million Unit Operations / Processes)
Figure 13.55 Novel Cell Sorting Products and Solutions Market for Sperm Cells, 2019-2030 (Million Unit Operations / Processes)
Figure 13.56 Novel Cell Sorting Products and Solutions Market for TCR Cells, 2019-2030 (Million Unit Operations / Processes)
Figure 13.57 Novel Cell Sorting Products and Solutions Market for TIL Cells, 2019-2030 (Million Unit Operations / Processes)
Figure 13.58 Novel Cell Sorting Products and Solutions Market for Tumor / Cancer Cells, 2019-2030 (Million Unit Operations / Processes)
Figure 13.59 Novel Cell Sorting Products and Solutions Market for Less Than 5 µm Cell Size, 2019-2030 (USD Million)
Figure 13.60 Novel Cell Sorting Products and Solutions Market for 5-10 µm Cell Size, 2019-2030 (USD Million)
Figure 13.61 Novel Cell Sorting Products and Solutions Market for 10-15 µm Cell Size, 2019-2030 (USD Million)
Figure 13.62 Novel Cell Sorting Products and Solutions Market for 15-25 µm Cell Size, 2019-2030 (USD Million)
Figure 13.63 Novel Cell Sorting Products and Solutions Market for Greater Than 25 µm Cell Size, 2019-2030 (USD Million)
Figure 13.64 Novel Cell Sorting Products and Solutions Market for Less Than 5 µm Cell Size, 2019-2030 (Million Unit Operations / Processes)
Figure 13.65 Novel Cell Sorting Products and Solutions Market for 5-10 µm Cell Size, 2019-2030 (Million Unit Operations / Processes)
Figure 13.66 Novel Cell Sorting Products and Solutions Market for 10-15 µm Cell Size, 2019-2030 (Million Unit Operations / Processes)
Figure 13.67 Novel Cell Sorting Products and Solutions Market for 15-25 µm Cell Size, 2019-2030 (Million Unit Operations / Processes)
Figure 13.68 Novel Cell Sorting Products and Solutions Market for Greater Than 25 µm Cell Size, 2019-2030 (Million Unit Operations / Processes)
Figure 13.69 Novel Cell Sorting Products and Solutions Market in North America, 2019-2030 (USD Million)
Figure 13.70 Novel Cell Sorting Products and Solutions Market in Europe, 2019-2030 (USD Million)
Figure 13.71 Novel Cell Sorting Products and Solutions Market in Asia-Pacific, 2019-2030 (USD Million)
Figure 13.72 Novel Cell Sorting Products and Solutions Market in North America, 2019-2030 (Million Unit Operations / Processes)
Figure 13.73 Novel Cell Sorting Products and Solutions Market in Europe, 2019-2030 (Million Unit Operations / Processes)
Figure 13.74 Novel Cell Sorting Products and Solutions Market in Asia-Pacific, 2019-2030 (Million Unit Operations / Processes)
Figure 13.75 Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Research Studies, 2019-2030 (USD Million)
Figure 13.76 Buoyancy-activated Cell Sorters Market for Research Studies, 2019-2030 (USD Million)
Figure 13.77 Buoyancy-activated Consumables and Isolation Kits Market for Research Studies, 2019-2030 (USD Million)
Figure 13.78 Novel Cell Sorting Market for Magnetophoretics-based Products and Solutions for Research Studies, 2019-2030 (USD Million)
Figure 13.79 Magnetophoretics-based Cell Sorters Market for Research Studies, 2019-2030 (USD Million)
Figure 13.80 Magnetophoretics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (USD Million)
Figure 13.81 Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Research Studies, 2019-2030 (USD Million)
Figure 13.82 Microfluidics-based Cell Sorters Market for Research Studies, 2019-2030 (USD Million)
Figure 13.83 Microfluidics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (USD Million)
Figure 13.84 Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Research Studies, 2019-2030 (USD Million)
Figure 13.85 Optoelectronics-based Cell Sorters Market for Research Studies, 2019-2030 (USD Million)
Figure 13.86 Optoelectronics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (USD Million)
Figure 13.87 Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Research Studies, 2019-2030 (USD Million)
Figure 13.88 Other Advanced Technologies-based Cell Sorters Market for Research Studies, 2019-2030 (USD Million)
Figure 13.89 Other Advanced Technologies-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (USD Million)
Figure 13.90 Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Research Studies, 2019-2030 (Million Projects)
Figure 13.91 Novel Cell Sorting Market for Magnetophoretics-based Products and Solutions for Research Studies, 2019-2030 (Million Projects)
Figure 13.92 Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Research Studies, 2019-2030 (Million Projects)
Figure 13.93 Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Research Studies, 2019-2030 (Million Projects)
Figure 13.94 Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Research Studies, 2019-2030 (Million Projects)
Figure 13.95 Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Clinical Diagnostics, 2019-2030 (USD Million)
Figure 13.96 Buoyancy-activated Cell Sorters Market for Clinical Diagnostics, 2019-2030 (USD Million)
Figure 13.97 Buoyancy-activated Consumables and Isolation Kits Market for Clinical Diagnostics, 2019-2030 (USD Million)
Figure 13.98 Novel Cell Sorting Market for Magnetophoretics-based Products and Solutions for Clinical Diagnostics, 2019-2030 (USD Million)
Figure 13.99 Magnetophoretics-based Cell Sorters Market for Clinical Diagnostics, 2019-2030 (USD Million)
Figure 13.100 Magnetophoretics-based Consumables and Isolation Kits Market for Clinical Diagnostics, 2019-2030 (USD Million)
Figure 13.101 Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Clinical Diagnostics, 2019-2030 (USD Million)
Figure 13.102 Microfluidics-based Cell Sorters Market for Clinical Diagnostics, 2019-2030 (USD Million)
Figure 13.103 Microfluidics-based Consumables and Isolation Kits Market for Clinical Diagnostics, 2019-2030 (USD Million)
Figure 13.104 Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Clinical Diagnostics, 2019-2030 (USD Million)
Figure 13.105 Optoelectronics-based Cell Sorters Market for Clinical Diagnostics, 2019-2030 (USD Million)
Figure 13.106 Optoelectronics-based Consumables and Isolation Kits Market for Clinical Diagnostics, 2019-2030 (USD Million)
Figure 13.107 Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Clinical Diagnostics, 2019-2030 (USD Million)
Figure 13.108 Other Advanced Technologies-based Cell Sorters Market for Clinical Diagnostics, 2019-2030 (USD Million)
Figure 13.109 Other Advanced Technologies-based Consumables and Isolation Kits Market for Clinical Diagnostics, 2019-2030 (USD Million)
Figure 13.110 Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Clinical Diagnostics, 2019-2030 (Million Tests)
Figure 13.111 Novel Cell Sorting Market for Magnetophoretics-based Products and Solutions for Clinical Diagnostics, 2019-2030 (Million Tests)
Figure 13.112 Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Clinical Diagnostics, 2019-2030 (Million Tests)
Figure 13.113 Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Clinical Diagnostics, 2019-2030 (Million Tests)
Figure 13.114 Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Clinical Diagnostics, 2019-2030 (Million Tests)
Figure 13.115 Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 13.116 Buoyancy-activated Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 13.117 Buoyancy-activated Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 13.118 Novel Cell Sorting Market for Magnetophoretics-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 13.119 Magnetophoretics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 13.120 Magnetophoretics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 13.121 Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 13.122 Microfluidics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 13.123 Microfluidics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 13.124 Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 13.125 Optoelectronics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 13.126 Optoelectronics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 13.127 Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 13.128 Other Advanced Technologies-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 13.129 Other Advanced Technologies-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 13.130 Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Cell-based Therapeutics, 2019-2030 (Million Therapy Products)
Figure 13.131 Novel Cell Sorting Market for Magnetophoretics-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (Million Therapy Products)
Figure 13.132 Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (Million Therapy Products)
Figure 13.133 Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (Million Therapy Products)
Figure 13.134 Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (Million Therapy Products)
Figure 13.135 Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Other Applications, 2019-2030 (USD Million)
Figure 13.136 Buoyancy-activated Cell Sorters Market for Other Applications, 2019-2030 (USD Million)
Figure 13.137 Buoyancy-activated Consumables and Isolation Kits Market for Other Applications, 2019-2030 (USD Million)
Figure 13.138 Novel Cell Sorting Market for Magnetophoretics-based Products and Solutions for Other Applications, 2019-2030 (USD Million)
Figure 13.139 Magnetophoretics-based Cell Sorters Market for Other Applications, 2019-2030 (USD Million)
Figure 13.140 Magnetophoretics-based Consumables and Isolation Kits Market for Other Applications, 2019-2030 (USD Million)
Figure 13.141 Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Other Applications, 2019-2030 (USD Million)
Figure 13.142 Microfluidics-based Cell Sorters Market for Other Applications, 2019-2030 (USD Million)
Figure 13.143 Microfluidics-based Consumables and Isolation Kits Market for Other Applications, 2019-2030 (USD Million)
Figure 13.144 Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Other Applications, 2019-2030 (USD Million)
Figure 13.145 Optoelectronics-based Cell Sorters Market for Other Applications, 2019-2030 (USD Million)
Figure 13.146 Optoelectronics-based Consumables and Isolation Kits Market for Other Applications, 2019-2030 (USD Million)
Figure 13.147 Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Other Applications, 2019-2030 (USD Million)
Figure 13.148 Other Advanced Technologies-based Cell Sorters Market for Other Applications, 2019-2030 (USD Million)
Figure 13.149 Other Advanced Technologies-based Consumables and Isolation Kits Market for Other Applications, 2019-2030 (USD Million)
Figure 13.150 Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Other Applications, 2019-2030 (Million Treatment Procedures)
Figure 13.151 Novel Cell Sorting Market for Magnetophoretics-based Products and Solutions for Other Applications, 2019-2030 (Million Treatment Procedures)
Figure 13.152 Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Other Applications, 2019-2030 (Million Treatment Procedures)
Figure 13.153 Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Other Applications, 2019-2030 (Million Treatment Procedures)
Figure 13.154 Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Other Applications, 2019-2030 (Million Treatment Procedures)
LIST OF TABLES
Table 3.1 Conventional Flow Cytometers
Table 3.2 Microfluidics-based Cell Sorting Technologies
Table 4.1 Novel Cell Sorting Products and Solutions: Information on Type of Product and Basis for Separation
Table 4.2 Novel Cell Sorting Products and Solutions: Information on Type of Technology
Table 4.3 Novel Cell Sorting Products and Solutions: Information on Type of Cell Separation Approach and Type of Cell
Table 4.4 Novel Cell Sorters: Information on Product Specifications
Table 4.5 Novel Cell Sorting Products and Solutions: Developer Overview
Table 4.6 Novel Cell Sorting Products and Solutions: Information on End Use / Application
Table 4.7 Novel Cell Sorting Products and Solutions: Initiatives of Non-Industry Players
Table 6.1 NanoCellect Biomedical: Key Highlights
Table 6.2 NanoCellect Biomedical: Funding Instances
Table 6.3 NanoCellect Biomedical: Key Characteristics of WOLF® Cell Sorter and N1® Single Cell Dispenser
Table 6.4 NanoCellect Biomedical: Recent Developments and Future Outlook
Table 6.5 Innovative Biochips: Key Highlights
Table 6.6 Innovative Biochips: Funding Instances
Table 6.7 Innovative Biochips: Key Characteristics of SMART ALIQUOTOR, SMART ALIQUOTOR COMPACT EDITION and SMART ALIQUOTOR EXTENDED EDITION
Table 6.8 Innovative Biochips: Recent Developments and Future Outlook
Table 6.9 Cesca Therapeutics: Key Highlights
Table 6.10 Cesca Therapeutics: Key Characteristics of AUTOXPRESS®, CAR-TXPRESS™ and CELLXPRESS™
Table 6.11 Cesca Therapeutics: Recent Developments and Future Outlook
Table 6.12 Fluidigm: Key Highlights
Table 6.13 Fluidigm: Key Characteristics of C1™ System
Table 6.14 Fluidigm: Recent Developments and Future Outlook
Table 6.15 LumaCyte: Key Highlights
Table 6.16 LumaCyte: Funding Instances
Table 6.17 LumaCyte: Key Characteristics of Radiance™
Table 6.18 LumaCyte: Recent Developments and Future Outlook
Table 6.19 Union Biometrica: Key Highlights
Table 6.20 Union Biometrica: Key Characteristics of BioSorter® and COPAS™ FP
Table 6.21 Union Biometrica: Recent Developments and Future Outlook
Table 6.22 LevitasBio: Key Highlights
Table 6.23 LevitasBio: Key Characteristics of LeviCell System
Table 6.24 LevitasBio: Recent Developments and Future Outlook
Table 6.25 RareCyte®: Key Highlights
Table 6.26 RareCyte®: Key Characteristics of AccuCyte® Sample Preparation System and CyteFinder Instruments
Table 6.27 RareCyte®: Recent Developments and Future Outlook
Table 6.28 Cytonome: Key Highlights
Table 6.29 Cytonome: Key Characteristics of Cytonome GigaSort™, Cytonome Hydris™ and Cytonome Viva™
Table 6.30 Cytonome: Recent Developments and Future Outlook
Table 6.31 Namocell: Key Highlights
Table 6.32 Namocell: Key Characteristics of Namo™ Single Cell Dispenser and Hana™ Single Cell Dispenser
Table 6.33 Namocell: Recent Developments and Future Outlook
Table 7.1 STEMCELL Technologies: Key Highlights
Table 7.2 STEMCELL Technologies: Funding Instances
Table 7.3 STEMCELL Technologies: Product Portfolio
Table 7.4 STEMCELL Technologies: Recent Developments and Future Outlook
Table 7.5 Akadeum Life Sciences: Key Highlights
Table 7.6 Akadeum Life Sciences: Funding Instances
Table 7.7 Akadeum Life Sciences: Product Portfolio
Table 7.8 Akadeum Life Sciences: Recent Developments and Future Outlook
Table 7.9 QIAGEN: Key Highlights
Table 7.10 QIAGEN: Product Portfolio
Table 7.11 QIAGEN: Recent Developments and Future Outlook
Table 7.12 RareCyte®: Product Portfolio
Table 7.13 ScreenCell: Key Highlights
Table 7.14 ScreenCell: Product Portfolio
Table 7.15 ScreenCell: Recent Developments and Future Outlook
Table 8.1 Patent Analysis: CPC Symbol Definitions
Table 8.2 Patent Analysis: Most Popular CPC Symbols
Table 8.3 Patent Analysis: List of Top CPC Symbols
Table 8.4 Novel Cell Sorting Products and Solutions: Summary of Patent Benchmarking Analysis
Table 8.5 Novel Cell Sorting Products and Solutions: Categorizations based on Weighted Valuation Scores
Table 8.6 Leading Patents: Distribution by Relative Valuation
Table 8.7 Leading Patents: Distribution by Number of Citations
Table 9.1 Novel Cell Sorting Products and Solutions: List of Publications, 2013-2018
Table 10.1 Novel Cell Sorting Products and Solutions: List of Partnerships, 2014-Q1 2019
Table 10.2 Novel Cell Sorting Products and Solutions: Leading Players in Terms of Number of Partnerships Established with Different Types of Partners
Table 10.3 Most Active Players: Distribution by Number of Partnerships
Table 11.1 Novel Cell Sorting Products and Solutions: List of Funding Instances, 2014-Q1 2019
Table 11.2 Novel Cell Sorting Products and Solutions: Summary of Investments
Table 13.1 Novel Cell Sorting Products and Solutions: Current and Future Market Share of Novel Technologies, 2019 and 2030
Table 13.2 Novel Cell Sorting Products and Solutions: Distribution of Different Types of Cells by Size
Table 14.1 Akadeum Life Sciences: Key Highlights
Table 14.2 LumaCyte: Key Highlights
Table 14.3 Namocell: Key Highlights
Table 15.1 Novel Cell Sorting Products and Solutions: Key Takeaways
Table 16.1 Novel Cell Sorting Products and Solutions: Distribution by Type of Product
Table 16.2 Novel Cell Sorting Products and Solutions: Distribution by Basis for Separation
Table 16.3 Novel Cell Sorting Products and Solutions: Distribution by Cell Sorting Technology
Table 16.4 Novel Cell Sorting Products and Solutions: Distribution of Developers by Type of Technology
Table 16.5 Novel Cell Sorting Products and Solutions: Distribution by Cell Separation Approach
Table 16.6 Novel Cell Sorting Products and Solutions: Distribution by Type of Cell
Table 16.7 Novel Cell Sorting Products and Solutions: Distribution by Type of Technology and Type of Cell
Table 16.8 Novel Cell Sorting Products and Solutions: Popular Cell Types
Table 16.9 Novel Cell Sorting Products and Solutions: Distribution by End Use / Application
Table 16.10 Novel Cell Sorting Products and Solutions: Distribution of Industry Players by Year of Establishment
Table 16.11 Novel Cell Sorting Products and Solutions: Distribution of Industry Players by Geographical Location
Table 16.12 Novel Cell Sorting Products and Solutions: Distribution of Industry Players by Company Size
Table 16.13 Novel Cell Sorting Products and Solutions: Distribution of Industry Players by Type of Offering
Table 16.14 Leading Developers: Distribution by Number of Products
Table 16.15 Cesca Therapeutics: Net Revenues, FY 2014-H1 FY 2019 (USD Million)
Table 16.16 Cesca Therapeutics: Distribution of Net Revenues by Business Segment, FY 2018 (USD Million)
Table 16.17 Cesca Therapeutics: Distribution of Net Revenues by Products Offered in Device Segment, FY 2018 (USD Million)
Table 16.18 Cesca Therapeutics: Distribution of Net Revenues by Region, FY 2018 (USD Million)
Table 16.19 Fluidigm: Net Revenues, FY 2014-H1 FY 2019 (USD Million)
Table 16.20 Fluidigm: Distribution of Net Revenues by Type of Offering, FY 2018 (USD Million)
Table 16.21 Fluidigm: Fluidigm: Distribution of Net Revenues by Region, FY 2018 (USD Million)
Table 16.22 QIAGEN: Net Sales, FY 2014-H1 FY 2019 (USD Million)
Table 16.23 QIAGEN: Distribution of Net Sales by Product Segments, FY 2018 (USD Million)
Table 16.24 QIAGEN: Distribution of Net Sales by Customer Segments, FY 2018 (USD Million)
Table 16.25 QIAGEN: Distribution of Net Sales by Region, FY 2018 (USD Million)
Table 16.26 Patent Analysis: Distribution by Type
Table 16.27 Patent Analysis: Cumulative Year-wise Trend, 2014-2018
Table 16.28 Patent Analysis: Distribution by Geographical Location
Table 16.29 Patent Analysis: Distribution by CPC Symbols (Top 20)
Table 16.30 Most Active Industry Players: Distribution by Number of Patents
Table 16.31 Most Active Non-Industry Players: Distribution by Number of Patents
Table 16.32 Patent Analysis: Benchmarking by Patent Characteristics
Table 16.33 Patent Analysis: Benchmarking by Number of Patents Published across Different Geographies
Table 16.34 Patent Analysis: Benchmarking by Number of International Patents
Table 16.35 Patent Analysis: Distribution by Patent Age, 2014-2018
Table 16.36 Patent Analysis: Distribution by Geography and Publication Year, 2014-2018
Table 16.37 Patent Analysis: Distribution by Relative Valuation
Table 16.38 Publication Analysis: Cumulative Year-wise Trend, 2014-2018
Table 16.39 Publication Analysis: Distribution by Cell Sorting Technology
Table 16.40 Publication Analysis: Distribution by End Use / Application Area
Table 16.41 Publication Analysis: Distribution by Type of Cell
Table 16.42 Publication Analysis: Distribution by Target Disease Indication
Table 16.43 Publication Analysis: Distribution by Type of Organization Involved
Table 16.44 Most Active Players: Distribution by Number of Publications
Table 16.45 Most Active Players: Geographical Distribution by Number of Publications
Table 16.46 Key Journals: Distribution by Number of Publications
Table 16.47 Partnerships and Collaborations: Cumulative Year-wise Trend, 2014-Q1 2019
Table 16.48 Partnerships and Collaborations: Distribution by Type of Partnership
Table 16.49 Partnerships and Collaborations: Year-wise Trend by Type of Partnership
Table 16.50 Partnerships and Collaborations: Distribution by Cell Sorting Technology
Table 16.51 Partnerships and Collaborations: Year-wise Trend by Cell Sorting Technology
Table 16.52 Partnerships and Collaborations: Distribution by Type of Partner
Table 16.53 Most Active Players: Distribution by Number of Partnerships
Table 16.54 Most Active Players: Geographical Distribution by Number of Partnerships
Table 16.55 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 16.56 Funding and Investments: Distribution of Industry Players by Year of Establishment and Type of Funding, 2014-Q1 2019
Table 16.57 Funding and Investments: Distribution of Amount Invested by Focus Area and Type of Funding, 2014-Q1 2019
Table 16.58 Funding and Investments: Cumulative Year-wise Trend, 2014-Q1 2019
Table 16.59 Funding and Investments: Cumulative Amount Invested by Year, 2014-Q1 2019 (USD Million)
Table 16.60 Funding and Investments: Distribution by Type of Funding
Table 16.61 Funding and Investments: Distribution by Amount Invested and Type of Funding (USD Million)
Table 16.62 Popular Cell Sorting Technologies: Distribution by Number of Funding Instances
Table 16.63 Popular Cell Sorting Technologies: Distribution by Amount Invested (USD Million)
Table 16.64 Funding and Investments: Year-wise Trend of Amount Invested across Different Cell Sorting Technologies, 2014-Q1 2019 (USD Million)
Table 16.65 Most Active Players: Distribution by Number of Instances
Table 16.66 Most Active Players: Distribution by Capital Amount Raised (USD Million)
Table 16.67 Most Active Investors: Distribution by Number of Instances
Table 16.68 Funding and Investments: Geographical Distribution by Amount Invested (USD Million)
Table 16.69 Global Demand for Novel Cell Sorting Products and Solutions, 2019-2030 (Million Unit Operations / Processes)
Table 16.70 Global Demand for Novel Cell Sorting Products and Solutions: Distribution by End Use / Application, 2019 and 2030
Table 16.71 Global Demand for Novel Cell Sorting Products and Solutions for Research Studies, 2019-2030 (Million Projects)
Table 16.72 Global Demand for Novel Cell Sorting Products and Solutions for Clinical Diagnostics, 2019-2030 (Million Tests)
Table 16.73 Global Demand for Novel Cell Sorting Products and Solutions for Cell-based Therapeutics, 2019-2030 (Million Therapy Products)
Table 16.74 Global Demand for Novel Cell Sorting Products and Solutions for Other Applications, 2019-2030 (Million Treatment Procedures)
Table 16.75 Global Demand for Novel Cell Sorting Products and Solutions: Distribution by Geography, 2019 and 2030
Table 16.76 Demand for Novel Cell Sorting Products and Solutions in North America, 2019-2030 (Million Unit Operations / Processes)
Table 16.77 Demand for Novel Cell Sorting Products and Solutions in North America for Research Studies, 2019-2030 (Million Projects)
Table 16.78 Demand for Novel Cell Sorting Products and Solutions in North America for Clinical Diagnostics, 2019-2030 (Million Tests)
Table 16.79 Demand for Novel Cell Sorting Products and Solutions in North America for Cell-based Therapeutics, 2019-2030 (Million Therapy Products)
Table 16.80 Demand for Novel Cell Sorting Products and Solutions in North America for Other Applications, 2019-2030 (Million Treatment Procedures)
Table 16.81 Demand for Novel Cell Sorting Products and Solutions in Europe, 2019-2030 (Million Unit Operations / Processes)
Table 16.82 Demand for Novel Cell Sorting Products and Solutions in Europe for Research Studies, 2019-2030 (Million Projects)
Table 16.83 Demand for Novel Cell Sorting Products and Solutions in Europe for Clinical Diagnostics, 2019-2030 (Million Tests)
Table 16.84 Demand for Novel Cell Sorting Products and Solutions in Europe for Cell-based Therapeutics, 2019-2030 (Million Therapy Products)
Table 16.85 Demand for Novel Cell Sorting Products and Solutions in Europe for Other Applications, 2019-2030 (Million Treatment Procedures)
Table 16.86 Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific, 2019-2030 (Million Unit Operations / Processes)
Table 16.87 Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Research Studies, 2019-2030 (Million Projects)
Table 16.88 Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Clinical Diagnostics, 2019-2030 (Million Tests)
Table 16.89 Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Cell-based Therapeutics, 2019-2030 (Million Therapy Products)
Table 16.90 Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Other Applications, 2019-2030 (Million Treatment Procedures)
Table 16.91 Overall Novel Cell Sorting Products and Solutions Market, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.92 Overall Novel Cell Sorting Products and Solutions Market, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Unit Operations / Processes)
Table 16.93 Novel Cell Sorting Products and Solutions Market for Cell Sorters, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.94 Novel Cell Sorting Products and Solutions Market for Consumables and Isolation Kits, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.95 Novel Cell Sorting Products and Solutions Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.96 Novel Cell Sorting Products and Solutions Market for Clinical Diagnostics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.97 Novel Cell Sorting Products and Solutions Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.98 Novel Cell Sorting Products and Solutions Market for Other Applications, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.99 Novel Cell Sorting Products and Solutions Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Projects)
Table 16.100 Novel Cell Sorting Products and Solutions Market for Clinical Diagnostics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Tests)
Table 16.101 Novel Cell Sorting Products and Solutions Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Therapy Products)
Table 16.102 Novel Cell Sorting Products and Solutions Market for Other Applications, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Treatment Procedures)
Table 16.103 Novel Cell Sorting Products and Solutions Market for Academic Institutes, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.104 Novel Cell Sorting Products and Solutions Market for Clinical Testing Labs, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.105 Novel Cell Sorting Products and Solutions Market for Commercial Organizations, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.106 Novel Cell Sorting Products and Solutions Market for Hospitals, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.107 Novel Cell Sorting Products and Solutions Market for Academic Institutes, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Unit Operations / Processes)
Table 16.108 Novel Cell Sorting Products and Solutions Market for Clinical Testing Labs, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Unit Operations / Processes)
Table 16.109 Novel Cell Sorting Products and Solutions Market for Commercial Organizations, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Unit Operations / Processes)
Table 16.110 Novel Cell Sorting Products and Solutions Market for Hospitals, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Unit Operations / Processes)
Table 16.111 Novel Cell Sorting Products and Solutions Market for Buoyancy-activated, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.112 Novel Cell Sorting Products and Solutions Market for Magnetophoretics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.113 Novel Cell Sorting Products and Solutions Market for Microfluidics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.114 Novel Cell Sorting Products and Solutions Market for Optoelectronics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.115 Novel Cell Sorting Products and Solutions Market for Other Advanced Technologies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.116 Novel Cell Sorting Products and Solutions Market for Buoyancy-activated, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Unit Operations / Processes)
Table 16.117 Novel Cell Sorting Products and Solutions Market for Magnetophoretics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Unit Operations / Processes)
Table 16.118 Novel Cell Sorting Products and Solutions Market for Microfluidics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Unit Operations / Processes)
Table 16.119 Novel Cell Sorting Products and Solutions Market for Optoelectronics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Unit Operations / Processes)
Table 16.120 Novel Cell Sorting Products and Solutions Market for Other Advanced Technologies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Unit Operations / Processes)
Table 16.121 Novel Cell Sorting Products and Solutions Market for Adult Stem Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.122 Novel Cell Sorting Products and Solutions Market for CAR-T Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.123 Novel Cell Sorting Products and Solutions Market for Circulating Fetal Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.124 Novel Cell Sorting Products and Solutions Market for Circulating Tumor Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.125 Novel Cell Sorting Products and Solutions Market for Dendritic Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.126 Novel Cell Sorting Products and Solutions Market for Embryonic Stem Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.127 Novel Cell Sorting Products and Solutions Market for Insect Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.128 Novel Cell Sorting Products and Solutions Market for Induced Pluripotent Stem Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.129 Novel Cell Sorting Products and Solutions Market for Microbial Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.130 Novel Cell Sorting Products and Solutions Market for Sperm Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.131 Novel Cell Sorting Products and Solutions Market for TCR Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.132 Novel Cell Sorting Products and Solutions Market for TIL Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.133 Novel Cell Sorting Products and Solutions Market for Tumor / Cancer Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.134 Novel Cell Sorting Products and Solutions Market for Adult Stem Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Unit Operations / Processes)
Table 16.135 Novel Cell Sorting Products and Solutions Market for CAR-T Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Unit Operations / Processes)
Table 16.136 Novel Cell Sorting Products and Solutions Market for Circulating Fetal Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Unit Operations / Processes)
Table 16.137 Novel Cell Sorting Products and Solutions Market for Circulating Tumor Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Unit Operations / Processes)
Table 16.138 Novel Cell Sorting Products and Solutions Market for Dendritic Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Unit Operations / Processes)
Table 16.139 Novel Cell Sorting Products and Solutions Market for Embryonic Stem Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Unit Operations / Processes)
Table 16.140 Novel Cell Sorting Products and Solutions Market for Insect Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Unit Operations / Processes)
Table 16.141 Novel Cell Sorting Products and Solutions Market for Induced Pluripotent Stem Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Unit Operations / Processes)
Table 16.142 Novel Cell Sorting Products and Solutions Market for Microbial Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Unit Operations / Processes)
Table 16.143 Novel Cell Sorting Products and Solutions Market for Sperm Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Unit Operations / Processes)
Table 16.144 Novel Cell Sorting Products and Solutions Market for TCR Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Unit Operations / Processes)
Table 16.145 Novel Cell Sorting Products and Solutions Market for TIL Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Unit Operations / Processes)
Table 16.146 Novel Cell Sorting Products and Solutions Market for Tumor / Cancer Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Unit Operations / Processes)
Table 16.147 Novel Cell Sorting Products and Solutions Market for Less Than 5 µm Cell Size, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.148 Novel Cell Sorting Products and Solutions Market for 5-10 µm Cell Size, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.149 Novel Cell Sorting Products and Solutions Market for 10-15 µm Cell Size, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.150 Novel Cell Sorting Products and Solutions Market for 15-25 µm Cell Size, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.151 Novel Cell Sorting Products and Solutions Market for Greater Than 25 µm Cell Size, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.152 Novel Cell Sorting Products and Solutions Market for Less Than 5 µm Cell Size, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Unit Operations / Processes)
Table 16.153 Novel Cell Sorting Products and Solutions Market for 5-10 µm Cell Size, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Unit Operations / Processes)
Table 16.154 Novel Cell Sorting Products and Solutions Market for 10-15 µm Cell Size, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Unit Operations / Processes)
Table 16.155 Novel Cell Sorting Products and Solutions Market for 15-25 µm Cell Size, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Unit Operations / Processes)
Table 16.156 Novel Cell Sorting Products and Solutions Market for Greater Than 25 µm Cell Size, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Unit Operations / Processes)
Table 16.157 Novel Cell Sorting Products and Solutions Market in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.158 Novel Cell Sorting Products and Solutions Market in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.159 Novel Cell Sorting Products and Solutions Market in Asia-Pacific, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.160 Novel Cell Sorting Products and Solutions Market in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Unit Operations / Processes)
Table 16.161 Novel Cell Sorting Products and Solutions Market in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Unit Operations / Processes)
Table 16.162 Novel Cell Sorting Products and Solutions Market in Asia-Pacific, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Unit Operations / Processes)
Table 16.163 Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.164 Buoyancy-activated Cell Sorters Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.165 Buoyancy-activated Consumables and Isolation Kits Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.166 Novel Cell Sorting Market for Magnetophoretics-based Products and Solutions for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.167 Magnetophoretics-based Cell Sorters Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.168 Magnetophoretics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.169 Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.170 Microfluidics-based Cell Sorters Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.171 Microfluidics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.172 Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.173 Optoelectronics-based Cell Sorters Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.174 Optoelectronics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.175 Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.176 Other Advanced Technologies-based Cell Sorters Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.177 Other Advanced Technologies-based Consumables and Isolation Kits Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.178 Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Projects)
Table 16.179 Novel Cell Sorting Market for Magnetophoretics-based Products and Solutions for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Projects)
Table 16.180 Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Projects)
Table 16.181 Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Projects)
Table 16.182 Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Projects)
Table 16.183 Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Clinical Diagnostics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.184 Buoyancy-activated Cell Sorters Market for Clinical Diagnostics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.185 Buoyancy-activated Consumables and Isolation Kits Market for Clinical Diagnostics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.186 Novel Cell Sorting Market for Magnetophoretics-based Products and Solutions for Clinical Diagnostics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.187 Magnetophoretics-based Cell Sorters Market for Clinical Diagnostics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.188 Magnetophoretics-based Consumables and Isolation Kits Market for Clinical Diagnostics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.189 Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Clinical Diagnostics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.190 Microfluidics-based Cell Sorters Market for Clinical Diagnostics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.191 Microfluidics-based Consumables and Isolation Kits Market for Clinical Diagnostics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.192 Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Clinical Diagnostics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.193 Optoelectronics-based Cell Sorters Market for Clinical Diagnostics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.194 Optoelectronics-based Consumables and Isolation Kits Market for Clinical Diagnostics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.195 Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Clinical Diagnostics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.196 Other Advanced Technologies-based Cell Sorters Market for Clinical Diagnostics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.197 Other Advanced Technologies-based Consumables and Isolation Kits Market for Clinical Diagnostics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.198 Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Clinical Diagnostics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Tests)
Table 16.199 Novel Cell Sorting Market for Magnetophoretics-based Products and Solutions for Clinical Diagnostics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Tests)
Table 16.200 Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Clinical Diagnostics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Tests)
Table 16.201 Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Clinical Diagnostics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Tests)
Table 16.202 Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Clinical Diagnostics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Tests)
Table 16.203 Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.204 Buoyancy-activated Cell Sorters Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.205 Buoyancy-activated Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.206 Novel Cell Sorting Market for Magnetophoretics-based Products and Solutions for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.207 Magnetophoretics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.208 Magnetophoretics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.209 Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.210 Microfluidics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.211 Microfluidics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.212 Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.213 Optoelectronics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.214 Optoelectronics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.215 Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.216 Other Advanced Technologies-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.217 Other Advanced Technologies-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.218 Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Therapy Products)
Table 16.219 Novel Cell Sorting Market for Magnetophoretics-based Products and Solutions for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Therapy Products)
Table 16.220 Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Therapy Products)
Table 16.221 Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Therapy Products)
Table 16.222 Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Therapy Products)
Table 16.223 Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Other Applications, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.224 Buoyancy-activated Cell Sorters Market for Other Applications, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.225 Buoyancy-activated Consumables and Isolation Kits Market for Other Applications, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.226 Novel Cell Sorting Market for Magnetophoretics-based Products and Solutions for Other Applications, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.227 Magnetophoretics-based Cell Sorters Market for Other Applications, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.228 Magnetophoretics-based Consumables and Isolation Kits Market for Other Applications, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.229 Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Other Applications, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.230 Microfluidics-based Cell Sorters Market for Other Applications, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.231 Microfluidics-based Consumables and Isolation Kits Market for Other Applications, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.232 Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Other Applications, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.233 Optoelectronics-based Cell Sorters Market for Other Applications, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.234 Optoelectronics-based Consumables and Isolation Kits Market for Other Applications, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.235 Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Other Applications, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.236 Other Advanced Technologies-based Cell Sorters Market for Other Applications, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.237 Other Advanced Technologies-based Consumables and Isolation Kits Market for Other Applications, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.238 Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Other Applications, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Treatment Procedures)
Table 16.239 Novel Cell Sorting Market for Magnetophoretics-based Products and Solutions for Other Applications, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Treatment Procedures)
Table 16.240 Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Other Applications, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Treatment Procedures)
Table 16.241 Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Other Applications, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Treatment Procedures)
Table 16.242 Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Other Applications, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Treatment Procedures)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook